• Issue

    European Journal of Heart Failure Supplements: Volume 5, Issue S1

    1-212
    June 2006
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Abstracts

Free Access

35 B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure: the BIC study

N. Aspromonte,  M. Feola,  M. Milli,  A. D'Eri,  F. Noventa,  P. Giovinazzo,  L. Milani,  V. Valle, 
  • Page: 1
  • First Published: 20 July 2007
Free Access

36 Prognostic role of proinflammatory and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure

K. Miettinen,  J.P.E. Lassus,  J. Magga,  V.-P. Harjola,  K. Punnonen,  M.S. Nieminen,  M. Laakso,  K. Peuhkurinen,  on behalf of FINN-AKVA study group , 
  • Pages: 1-2
  • First Published: 20 July 2007
Free Access

37 Epidemiology and prognosis of octogenarians with acute heart failure. Insights from the Italian Registry on Acute Heart Failure

D. Miani,  C. Fresco,  M.C. Albanese,  M. Frigerio,  D. Lucci,  G. Cacciatore,  A.P. Maggioni,  L. Tavazzi, 
  • Page: 2
  • First Published: 20 July 2007
Free Access

38 Comparison between patients with de novo acute heart failure and acute decompensation of chronic heart failure: data from the Italian Survey of acute heart failure

G. Cacciatore,  M. Porcu,  A.P. Maggioni,  D. Lucci,  F. Oliva,  G. Ansalone,  L. Tavazzi, 
  • Page: 2
  • First Published: 20 July 2007
Free Access

39 Prevalence and prognostic role of hyponatremia in 2807 patients admitted for acute heart failure in year 2004

A.P. Maggioni,  G. Ansalone,  G. Cacciatore,  F. Oliva,  M. Porcu,  D. Lucci,  L. Gonzini,  L. Tavazzi,  on behalf of Acute Heart Failure Registry Investigators , 
  • Pages: 2-3
  • First Published: 20 July 2007
Free Access

40 Clinical characteristics and NT-pro B-type natriuretic peptide levels of contemporary patients presenting to emergency departments with acute decompensated heart failure

G. Moe,  Z. Mariano,  B. Steinhart,  Canadian IMPROVE-CHF Study investigators , 
  • Page: 3
  • First Published: 20 July 2007
Free Access

41 Circulating indices of collagen turnover during treatment of acute decompensation in chronic heart failure patients

D.N. Tziakas,  G.K. Chalikias,  D.A. Stakos,  S.B. Chatzikyriakou,  I.K. Tentes,  A.X. Kortsaris,  D.I. Hatseras, 
  • Page: 3
  • First Published: 20 July 2007
Free Access

42 Beta-blocker prescription in acute heart failure during hospitalization and impact on outpatients prescription at 6 months

P. Morais Sarmento,  C. Fonseca,  F. Marques,  I. Sousa,  J. Silvestre,  F. Ceia,  A. Aleixo, 
  • Pages: 3-4
  • First Published: 20 July 2007
Free Access

43 Relationship between renal function and in-hospital all cause death in patients with Acute Heart failure

A.P. Maggioni,  D. Lucci,  S. Baldasseroni,  G. Ansalone,  G. Cacciatore,  F. Oliva,  M. Porcu,  L. Tavazzi,  on behalf of Acute Heart Failure Registry Investigators , 
  • Page: 4
  • First Published: 20 July 2007
Free Access

44 Post-discharge referral to an outpatient clinic and the risk of readmission after a first hospitalisation for acute heart failure

S. Verde,  M. Mariani,  C. Bianchi,  S. Pirelli,  R. De Maria, 
  • Page: 4
  • First Published: 20 July 2007
Free Access

45 Determinants and clinical presentation of pulmonary edema in current hospital population

B. Kozlowski,  M. Michalkowska,  K. Wolkowska,  M. Prejbisz,  W. Pikto-Pietkiewicz,  T. Pasierski, 
  • Pages: 4-5
  • First Published: 20 July 2007
Free Access

46 Predictors of the occurrence of hypotension after levosimendan in decompensated systolic heart failure

J. Silva-Cardoso,  J. Ferreira,  A. Oliveira-Soares,  J. Martins-Campos,  C. Fonseca,  R. Seabra-Gomes,  R. Ferreira,  C. Abreu-Lima,  on behalf of PORTLAND study investigators , 
  • Page: 5
  • First Published: 20 July 2007
Free Access

47 Serial NTproBNP measurements for the prediction of 30-day-mortality in patients with decompensated heart failure and cardiogenic shock

C. Luers,  K. Rueter,  S. Kleta,  R. Wachter,  A. Schmidt,  L. Binder,  B. Pieske, 
  • Page: 5
  • First Published: 20 July 2007
Free Access

48 Elderly patients hospitalized with acute heart failure: mortality and clinical predictors

D.A. Pascual Figal,  B. Redondo,  J.A. Hurtado,  P. Penafiel,  D. Saura,  M.J. Antolinos,  S. Moreno,  M. Valdes, 
  • Page: 6
  • First Published: 20 July 2007
Free Access

49 Improvement in risk stratification with the combination of the tumoral marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure

J. Nunez,  E. Nunez,  L. Consuegra,  J. Sanchis,  V. Bodi,  V. Bertomeu,  L. Facila,  A. Llacer, 
  • Page: 6
  • First Published: 20 July 2007
Free Access

50 Left ventricular unloading effects of NT-proBNP are associated with increased collagen degradation in patients with acute decompensation of chronic heart failure

D.N. Tziakas,  G.K. Chalikias,  D.A. Stakos,  S.B. Chatzikyriakou,  I.K. Tentes,  A.X. Kortsaris,  D.I. Hatseras, 
  • Page: 6
  • First Published: 20 July 2007
Free Access

51 Blood pressure at hospital admission for acute heart failure strongly predicts in-hospital outcome

A.P. Maggioni,  G. Fabbri,  L. Gonzini,  G. Ansalone,  G. Cacciatore,  F. Oliva,  M. Porcu,  L. Tavazzi,  on behalf of Acute Heart Failure Registry Investigators , 
  • Page: 7
  • First Published: 20 July 2007
Free Access

52 Increase in BNP levels identify patients at high risk of death after myocardial infarction

M. Grabowski,  K.J. Filipiak,  L.A. Malek,  G. Karpinski,  R. Glowczynska,  P. Stolarz,  R. Rudowski,  G. Opolski, 
  • Page: 7
  • First Published: 20 July 2007
Free Access

53 Admission BNP levels improve early risk stratification by Killip classes and TIMI risk score in STEMI patients treated with PCI

M. Grabowski,  K.J. Filipiak,  L.A. Malek,  G. Karpinski,  R. Glowczynska,  P. Stolarz,  R. Rudowski,  G. Opolski, 
  • Pages: 7-8
  • First Published: 20 July 2007
Free Access

54 Risk stratification for acute heart failure patients: in-hospital mortality predictors. Data from the Italian survey on acute heart failure

A. Serio,  L. Tavazzi,  A.P. Maggioni,  D. Lucci,  G. Cacciatore,  G. Ansalone,  F. Oliva,  M. Porcu,  on behalf of Italian Survey on Acute Heart Failure Investigators , 
  • Page: 8
  • First Published: 20 July 2007
Free Access

55 Predictors of the effectiveness and safety of levosimendan in decompensated systolic heart failure

J. Silva-Cardoso,  J. Ferreira,  A. Oliveira-Soares,  J. Martins-Campos,  C. Fonseca,  R. Seabra-Gomes,  R. Ferreira,  C. Abreu-Lima,  on behalf of PORTLAND study investigators , 
  • Page: 8
  • First Published: 20 July 2007
Free Access

56 Withdrawn Effects of intensive lipid lowering with atorvastatin on congestive heart failure: subgroup analysis of the Treating to New Targets (TNT) study

D. Waters,  N.K. Wenger,  S.J. Lewis,  P. Deedwania,  V. Bittner,  K.K. Khush,  on behalf of TNT Steering Committe and Investigators , 
  • Pages: 8-9
  • First Published: 20 July 2007
Free Access

57 Clinically assessed hemodynamic profiles predict outcome in patients admitted with severe heart failure

A. Chinaglia,  B. Demichelis,  G. Gaschino,  F. Beqaray,  A. Ghisio,  D. Forno,  R. Trinchero, 
  • Page: 9
  • First Published: 20 July 2007
Free Access

58 Intra-aortic balloon counterpulsation for the treatment of post myocardial infarction cardiogenic shock: a single center long-term study

S. Drakos,  J. Kanakakis,  J. Terrovitis,  M. Bonios,  E. Tsagalou,  S. Efentakis,  E. Tsolakis,  J. Nanas, 
  • Page: 9
  • First Published: 20 July 2007
Free Access

59 In-hospital prognostic role of undiagnosed ethiology in acute heart failure syndromes

C. Pedone,  L. Di Diodoro,  E. Romboli,  P. Grazi,  G. Labanti,  V. Pedone,  S. Urbinati, 
  • Pages: 9-10
  • First Published: 20 July 2007
Free Access

60 Prognostic value of plasma NT-proBNP level at discharge after levosimendan treatment in acute/decompensated heart failure

M. Emdin,  R. Poletti,  C. Mammini,  A. Gabutti,  A. Giannoni,  M. Fontana,  L. Zyw,  C. Passino, 
  • Page: 10
  • First Published: 20 July 2007
Free Access

61 Prognostic importance of renal dysfunction in patients with acute decompencated heart failure

Z. Kobolava,  E. Pavlikova,  I. Merai,  A. Yurovski,  V. Moiseyev, 
  • Page: 10
  • First Published: 20 July 2007
Free Access

62 Low incidence of acute heart failure in adults with acute myocarditis

R. Vidal,  E. Abu Assi,  C. Pena Gil,  A. Garcia,  A. Garcia Acuna,  M. Jaquet, 
  • Page: 10
  • First Published: 20 July 2007
Free Access

63 Effects of levosimendan on cardiac function, morphology and survival in the mouse model of doxorubicin induced acute heart failure

M. Lorentzon,  M. Scharin-Tang,  T. Ramunddal,  E. Omerovic, 
  • Page: 11
  • First Published: 20 July 2007
Free Access

64 24 and 72h BNP levels and in-hospital mortality in STEMI

A. Vojvodic,  G. Krljanac,  V. Giga,  M. Asanin,  S. Stankovic,  B. Stojanovic,  A. Milosevic,  Z. Vasiljevic, 
  • Page: 11
  • First Published: 20 July 2007
Free Access

65 Adverse renal effects of combined hydrochlorothiazide and ACE inhibitor therapy in rats with myocardial infarction

B. Westendorp,  I. Hamming,  G.J. Navis,  H. van Goor,  H. Buikema,  W.H. van Gilst,  R.G. Schoemaker, 
  • Page: 11
  • First Published: 20 July 2007
Free Access

66 Arterial wall properties in patients with chronic heart failure

Z.D. Kobalava,  V.S. Moiseev,  Y.V. Kotovskaya,  G.K. Kiyakbaev,  E.M. Ozova, 
  • Pages: 11-12
  • First Published: 20 July 2007
Free Access

67 Cerebrovascular disease as clinical determinant of cognitive impairment in patients with chronic heart failure under neurohormonal blockade

V. Ruiz-Ruiz,  J. Comin-Colet,  A. Ortega,  J. Morales,  S. Quinones,  N. Badosa,  B. Garcia-Bascunana,  J. Bruguera-Cortada, 
  • Page: 12
  • First Published: 20 July 2007
Free Access

68 Withdrawn Magnetic resonance and post infarction heart failure: evidence of surgically induced reverse remodeling

V. Dor,  M. Di Donato,  P. Croisille,  M. Sabatier,  F. Civaia, 
  • Page: 12
  • First Published: 20 July 2007
Free Access

69 Carvedilol restore cardiac calcium release channel structure and function in heart failure

S.-R. Xue, 
  • Pages: 12-13
  • First Published: 20 July 2007
Free Access

70 Bradykinin limits cardiomyocytic apoptosis via restoration of nitric oxide after cardioplegic arrest

C.H. Yeh,  T.P. Chen,  C.H. Lee,  Y.M. Lin,  P.J. Lin, 
  • Page: 13
  • First Published: 20 July 2007
Free Access

71 Effect of myocardial revascularization on left ventricular systolic function in patients with heart failure

A. Kosmider,  J. Zaslonka,  R. Jaszewski,  M. Banach,  M. Kosmider, 
  • Page: 13
  • First Published: 20 July 2007
Free Access

72 Multicenter clinical evaluation of the HeartMate II axial flow left ventricular assist device in patients with severe heart failure: hemodynamic effects, pump performance and quality of life

J.G. Rogers,  M. Strueber,  F.D. Pagani,  Y. Naka,  R.L. Kormos,  L. Chen,  C.A. Milano,  O.H. Frazier,  On behalf of HeartMate II Clinical Investigators , 
  • Pages: 13-14
  • First Published: 20 July 2007
Free Access

73 TandemHeart percutaneous ventricular assist device in cardiac surgery of patients with advanced and acute heart failure

A.A. Pitsis,  E. Visouli,  P. Dardas,  N.E. Mezilis,  G. Filippatos,  G. Bougioukas, 
  • Page: 14
  • First Published: 20 July 2007
Free Access

74 Can we use continuous monitoring of right ventricular pressures to predict hospitalisations in patients with severe chronic heart failure?

A. Serio,  S. Ghio,  M. Mangiavacchi,  S. Valsecchi,  I. Vicini,  C. Campana,  E. Gronda,  L. Tavazzi, 
  • Page: 14
  • First Published: 20 July 2007
Free Access

75 Kidney function in heart transplant patients during and after LVAD bridging

F. Wenzelburger,  H. Welp,  S. Klotz,  C. Schmid,  J. Stypmann,  G. Drees,  H.H. Scheld, 
  • Page: 15
  • First Published: 20 July 2007
Free Access

76 Regulation of G-protein coupled receptor kinases GRK2 and GRK5 in heart transplantation candidates supported by ventricular assist devices

H. Milting,  C. Schuermann,  L. Arusoglu,  M. Morshuis,  A. El Banayosy,  R. Koerfer, 
  • Page: 15
  • First Published: 20 July 2007
Free Access

77 Pacing mode influences exercise parameters in patients with implanted cardioverter defibrillators and impaired but not with preserved systolic function

M. Wonisch,  P. Lercher,  D. Scherr,  W. Kraxner,  R. Maier,  F.M. Fruhwald,  B. Rotman,  N. Watzinger, 
  • Pages: 15-16
  • First Published: 20 July 2007
Free Access

78 Use of a new prognostic index based on ambulatory blood pressure monitoring in predicting non-arrhythmic cardiac events after ICD implantation for MADIT II criteria

L. Antonini,  V. Pasceri,  S. Greco,  S. Malfatti,  M. Russo,  A. Varveri,  F. Colivicchi,  M. Santini, 
  • Page: 16
  • First Published: 20 July 2007
Free Access

79 Effect of different interventricular delays upon on exercise capacity and peak oxygen consumption during cardiac resynchronisation therapy

D.J. Fox,  A.P. Fitzpatrick,  R.S. Khattar,  S.G. Williams,  A. Borg,  M.C.S. Hall,  P. Clayton,  N.C. Davidson, 
  • Page: 16
  • First Published: 20 July 2007
Free Access

80 Experience on long term outcome of patients treated with cardiac resynchronisation therapy

C. Bonanno,  R. Ometto,  M. Paccanaro,  L. La Vecchia,  D. Facchin,  A. Fontanelli,  A. Proclemer, 
  • Pages: 16-17
  • First Published: 20 July 2007
Free Access

81 Prevention of sudden cardiac deaths with an implantable cardioverter defibrillator (ICD): a cost-benefit analysis in Sweden

H.B. Deniz,  A.J. Ward,  F. Malik,  L. Nicklasson,  J. Caro, 
  • Page: 17
  • First Published: 20 July 2007
Free Access

82 Gender differences in survival in patients treated with cardiac resynchronization therapy: the InSync/InSync ICD Italian Registries

E. Gronda,  M. Lunati,  M. Bocchiardo,  M. Santini,  M. Landolina,  G. Luzzi,  S. Valsecchi,  A. Denaro,  on behalf of InSync/InSync ICD Italian Registries Investigators , 
  • Page: 17
  • First Published: 20 July 2007
Free Access

83 Early and sustained effects of cardiac resynchronisation therapy on N-Terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony

F.M. Fruhwald,  A. Fahrleitner-Pammer,  N. Freemantle,  R. Berger,  J.G.F. Cleland,  on behalf of CARE-HF investigators , 
  • Pages: 17-18
  • First Published: 20 July 2007
Free Access

84 Left ventricular force frequency relationship in heart failure patients before and after cardiac resynchronisation therapy

W. Mullens,  J. Bartunek,  M. Goethals,  S. Verstreken,  P. Geelen,  B. De Bruyne,  H. De Raedt,  M. Vanderheyden, 
  • Page: 18
  • First Published: 20 July 2007
Free Access

85 Utility of a new left ventricular asynchrony index as a predictor of cardiac resynchronization therapy efficacy

M.C. Porciani,  A. Lilli,  R. Macioce,  F. Cappelli,  A. Pappone,  G. Ricciardi,  N. Musilli,  L. Padeletti, 
  • Page: 18
  • First Published: 20 July 2007
Free Access

86 Cardiac resynchronization therapy in atrial fibrillation: an InSync Italian Registry long-term follow-up

F. Oliva,  M. Gasparini,  A. Carboni,  F. Zanon,  A. Puglisi,  A. Curnis,  S. Valsecchi,  A. Denaro,  on behalf of InSync/InSync ICD Italian Registries Investigators , 
  • Pages: 18-19
  • First Published: 20 July 2007
Free Access

87 The effect of CRT on blood pressure, renal function and anaemia in patients with heart failure and cardiac dyssynchrony

J.G.F. Cleland,  J. Ghosh,  L. Tavazzi,  N. Freemantle,  M. Marijianowski,  L. Kappenberger,  D. Gras,  J.C. Daubert, 
  • Page: 19
  • First Published: 20 July 2007
Free Access

88 Trial-generated patient profiles for implant with electrical devices in chronic heart failure: real-world prevalence, outcomes and public health implications

G. Boriani,  C. Rapezzi,  A.P. Maggioni,  I. Diemberger,  M. Gorini,  G.F. Sinagra,  G. Di Pasquale,  L. Tavazzi,  on behalf of IN-CHF researchers , 
  • Page: 19
  • First Published: 20 July 2007
Free Access

89 Cardiac resynchronization in combination with Betablocker treatment in advanced Heart Failure (CARIBE-HF): the results of the CARIBE study

A.A. Grosu,  M. Senni,  A. Iacovoni,  M. Gori,  S. Bisetti,  T. De Santo,  P. Invernizzi,  A. Gavazzi, 
  • Pages: 19-20
  • First Published: 20 July 2007
Free Access

90 The effects of right ventricular pacing on ventricular synchrony studied by tissue Doppler echocardiography: A prospective study in patients undergoing single/dual chamber pacemaker implantation

M. Lotrionte,  R. Natali,  G. Biondi-Zoccai,  G. Comerci,  M. Savino,  A. Natale,  F. Loperfido,  P. Santarelli, 
  • Page: 20
  • First Published: 20 July 2007
Free Access

91 Cardiac resynchronisation is effective for patients with mild symptoms of heart failure

J.G.F. Cleland,  N. Freemantle,  E. Erdmann,  M.J. Calvert,  L. Tavazzi,  L. Kappenberger,  D. Gras,  J.C. Daubert, 
  • Page: 20
  • First Published: 20 July 2007
Free Access

92 Effect of chronic renal insufficiency on long term outcomes after cardiac resynchronization therapy

G. Lin,  P.A. Brady,  D.L. Hayes, 
  • Pages: 20-21
  • First Published: 20 July 2007
Free Access

93 Left ventricular function changes in a general pacemaker population

W. Mampuya,  F. Scazzuso,  L. Lavallee,  M. Poirier,  F. Ayala Paredes, 
  • Page: 21
  • First Published: 20 July 2007
Free Access

94 Effect of homocysteine induced oxidative stress on endothelial function in coronary slow flow

H. Tanriverdi,  H. Evrengul,  Y. Enli,  S. Tanriverdi,  O. Kuru,  D. Seleci,  A. Kaftan,  M. Kilic, 
  • Page: 21
  • First Published: 20 July 2007
Free Access

95 Post thrombolysis percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction

O. Mirolyubova,  A. Zavolozhin,  S. Goliushev, 
  • Pages: 21-22
  • First Published: 20 July 2007
Free Access

96 Simplified ultrasound method for measurement of coronary flow reserve

K.R. Bangaru Girish,  A. Kastanjan,  V. Terentiev,  J. Nelassov,  S. Zathonski, 
  • Page: 22
  • First Published: 20 July 2007
Free Access

97 Effect of dobutamine on QT dynamicity: an explanation for inotropic drugs-related mortality in chronic heart failure patients?

A. Pathak,  O. Xhaet,  P. van de Borne, 
  • Page: 22
  • First Published: 20 July 2007
Free Access

98 Left ventricular long axis function is impaired prior to deterioration of global systolic function in mitral stenosis

M. Cayli,  M. Kanadasi,  M. Demir,  E. Acarturk, 
  • Pages: 22-23
  • First Published: 20 July 2007
Free Access

99 The - 1171 5A/6A polymorphism of matrix metalloproteinase 3 gene predicts regurgitation and left ventricular remodelling in mitral valve prolapse patients

D. Oceandy,  R. Yusoff,  S.G. Ray,  L. Neyses, 
  • Page: 23
  • First Published: 20 July 2007
Free Access

100 Risk factors for “diastolic” heart failure after aortic valve replacement

W. Mistiaen,  P. Van Cauwelaert,  P. Muylaert,  F. Wuyts, 
  • Page: 23
  • First Published: 20 July 2007
Free Access

101 Plasma natriuretic peptides in aortic valve disease in relation to pressure and volume overload

P. Uusimaa,  J. Magga,  K. Ylitalo,  A. Turpeinen,  M. Hedman,  J. Kuusisto,  O. Vuolteenaho,  K. Peuhkurinen, 
  • Pages: 23-24
  • First Published: 20 July 2007
Free Access

102 Patients with aortic valve disease surviving pulmonary edema: does this event matter for mortality after aortic valve replacement?

W. Mistiaen,  P. Van Cauwelaert,  P. Muylaert, 
  • Page: 24
  • First Published: 20 July 2007
Free Access

103 Echocardiographic evaluation of left atrial function in mitral regurgitation and its relation to patient clinical profile

H. Badran,  A.K. Mostafa,  A. Serag,  H. Hassan,  T. Gazy, 
  • Page: 24
  • First Published: 20 July 2007
Free Access

104 Clinical profile of patients with aortic valve sclerosis referred to myocardial revascularization

B. Obrenovic-Kircanaski,  D. Trifunovic,  G. Krljanac,  N. Milic,  D. Panic,  P. Djukic,  on behalf of B. Obrenovic-Kircanski , 
  • Pages: 24-25
  • First Published: 20 July 2007
Free Access

105 Effect of acute ischemia in the cardiac mitochondrial function of patients with severe heart failure submitted to cardiac transplantation

P.F. Monteiro,  M. Paiva,  R.S. Carreira,  L.M. Goncalves,  M. Antunes,  L.A. Providencia, 
  • Page: 25
  • First Published: 20 July 2007
Free Access

106 Precipitating factors in the elderly patients admitted with the diagnosis of heart failure. Are easy to find?

R.C. Vidal Perez,  E. Abu Assi,  M. Paramo de Vega,  P. Rigueiro Veloso,  A. Varela Roman,  V. Lorenzo Zuniga,  A. Amaro Cendon, 
  • Pages: 25-26
  • First Published: 20 July 2007
Free Access

107 Three-year mortality of patients with congestive heart failure hospitalized at the internal dpt. of University hospital Brno

O. Ludka,  V. Musil,  Z. Pozdisek,  J. Spinar, 
  • Page: 26
  • First Published: 20 July 2007
Free Access

108 Progressive heart failure, rather than sudden death, accounts for most early deaths in patients with newly diagnosed heart failure

P.A. Mehta,  S.W. Dubrey,  H.F. McIntyre,  D.M. Walker,  S.M.C. Hardman,  G.C. Sutton,  T. McDonagh,  M.R. Cowie, 
  • Page: 26
  • First Published: 20 July 2007
Free Access

109 Has gender an influence on management and prognosis of heart failure patients?

M. Anguita,  M. Jimenez-Navarro,  J.C. Castillo,  on behalf of BADAPIC Investigators , 
  • Pages: 26-27
  • First Published: 20 July 2007
Free Access

110 Improving temporal trends in survival for patients with newly diagnosed heart failure in the UK general population

P.A. Mehta,  S.W. Dubrey,  H.F. McIntyre,  D.M. Walker,  S.M.C. Hardman,  G.C. Sutton,  T. McDonagh,  M.R. Cowie, 
  • Page: 27
  • First Published: 20 July 2007
Free Access

111 Factors related to short-term prognosis of patients admitted with heart failure

M. Jimenez-Navarro,  J.M. Garcia Pinilla,  A. Martinez,  M. Anguita,  F.J. Torres-Calvo,  on behalf of RAIC Investigators , 
  • Page: 27
  • First Published: 20 July 2007
Free Access

112 Heart failure with preserved and depressed left ventricular systolic function: features and prognosis in a multicenter registry of 4720 patients

J.C. Castillo,  M. Anguita,  M. Jimenez-Navarro,  on behalf of BADAPIC Investigators , 
  • Page: 27
  • First Published: 20 July 2007
Free Access

113 Natural history of congestive heart failure and associated cardiovascular diseases in outpatient HIV-infected subjects: Rationale and design of the HIV-HEART Study

T. Neumann,  P. Krings,  S. Esser,  S. Pankuweit,  J. Kondratieva,  R. Wachter,  A. Neumann,  R. Erbel,  on behalf of HIV-HEART Study Investigative Group , 
  • Page: 28
  • First Published: 20 July 2007
Free Access

114 Gender-related differences in the management of patients with congestive heart failure: A French observational study in 1917 patients

P. De Groote,  P. Assyag,  A. Ducardonnet,  M. Galinier,  R. Isnard,  G. Jondeau,  I. Leurs,  M. Komajda,  on behalf of IMPACT-RECO investigators , 
  • Page: 28
  • First Published: 20 July 2007
Free Access

115 Heart failure mortality due to ischemic etiology: is it the same in the Mediterranean lifestyle?

M. Jimenez-Navarro,  J.J. Gomez Doblas,  G. Gomez-Hernandez,  A. Dominguez Franco,  J.M. Garcia Pinilla,  A. Munoz Garcia,  A. Montiel-Trujillo,  E. De Teresa Galvan, 
  • Pages: 28-29
  • First Published: 20 July 2007
Free Access

116 Heart failure in hypertensive patients managed in Spanish primary care centres. The HICAP study

M. Luque,  B. De Rivas,  J.A. Divison,  E. Marquez,  R. Fernandez,  on behalf of HICAP Study investigators , 
  • Page: 29
  • First Published: 20 July 2007
Free Access

117 Trends in hospitalisation for heart failure in Andalucia (Spain) in the last decade

A.J. Munoz Garcia,  M. Jimenez-Navarro,  J.M. Garcia Pinilla,  J.J. Gomez Doblas,  A. Dominguez Franco,  C. Sanchez Gonzalez,  E. De Teresa Galvan, 
  • Page: 29
  • First Published: 20 July 2007
Free Access

118 Heart failure diagnostic procedures in randomly analyzed outpatient departments in Poland in 2005: Polkard project 2003–2005

M. Fedyk-Lukasik,  B. Wizner,  J. Dubiel,  T. Zdrojewski,  G. Opolski,  M. Czech,  B. Wyrzykowski,  T. Grodzicki, 
  • Page: 29
  • First Published: 20 July 2007
Free Access

119 Blood pressure in acute heart failure: relation to mortality at follow up

H. Sundberg,  P. Svensson,  J. Ostergren, 
  • Page: 30
  • First Published: 20 July 2007
Free Access

120 Evidence based practice for chronic failure beyond city limits

R.A. Clark,  S. Stewart,  on behalf of The CHF-GISCA Study Team & The CASE Study Team , 
  • Page: 30
  • First Published: 20 July 2007
Free Access

121 The STOP-HF Study. Screening TO Prevent Heart Failure: design and methodology

C. Conlon,  C. O'Loughlin,  M. McGrath,  A. Patle,  C. Kelleher,  M. Ledwidge,  K. McDonald,  on behalf of The STOP HF Investigators and St Vincents University Hospital , 
  • Page: 30
  • First Published: 20 July 2007
Free Access

122 HELUMA-registry: 10-year analysis of gender differences and treatment implementation in CHF

C. Zugck,  A. Fluegel,  L. Frankenstein,  M. Nelles,  M. Haass,  R. Winkler,  B. Rauch,  A. Remppis, 
  • Pages: 30-31
  • First Published: 20 July 2007
Free Access

123 Trends in hospitalisation for heart failure in Italy: an analysis of the national data-base from the National Ministry of Health

G. Reggiardo,  G. Gigli,  L. Lispi,  R. De Maria,  F. Oliva,  G. Pulignano,  L. Tarantini,  A. Di Lenarda, 
  • Page: 31
  • First Published: 20 July 2007
Free Access

124 Depression is associated with enhanced neurohormonal and inflammatory activation, and worse prognosis in patients with chronic heart failure

J.T. Parissis,  D. Farmakis,  M. Nikolaou,  K. Kourea,  V. Bistola,  F. Panou,  G. Filippatos,  D. Kremastinos, 
  • Page: 31
  • First Published: 20 July 2007
Free Access

125 Quality of life is independent of time since heart transplant in clinically stable patients

C. Klersy,  I. Michelini,  C. Campana,  L. Petrucci,  C. Goggi,  P.L. Politi,  C. Tinelli,  on behalf of Pavia Working Group on Quality of Life in Heart Transplant , 
  • Page: 32
  • First Published: 20 July 2007
Free Access

126 Helping estimate the life-benefits of therapy from the patient's perspective - HELPP study

S.L. Nabb,  A.C. Parker,  J.G.F. Cleland,  M. Wang,  D.M. Sharp, 
  • Page: 32
  • First Published: 20 July 2007
Free Access

127 Depression and quality of life in patients with diastolic and systolic heart failure

M. Hofmann,  L. Goedel-Meinen,  G. Elhardt,  S. Surwald,  L. Lutilsky,  K. Dennig, 
  • Pages: 32-33
  • First Published: 20 July 2007
Free Access

128 Quality of life in heart failure patients: comparison of four health-related quality of life questionnaires

D. Lane,  L. Baxter,  L. Jenkins,  Y. Tsang,  R.S. Taylor, 
  • Page: 33
  • First Published: 20 July 2007
Free Access

129 The impact of anxiety and depression in HF patients on overall quality of life and health

S.L. Nabb,  I.R. Manousos,  A.L. Clark,  J.G.F. Cleland, 
  • Page: 33
  • First Published: 20 July 2007
Free Access

130 Cognitive impairment in heart failure; a systematic review of literature

R.L.C. Vogels,  H.C. Weinstein,  J.M. Schroeder-Tanka, 
  • Pages: 33-34
  • First Published: 20 July 2007
Free Access

131 Patient preferences for communication regarding prognosis

P.H. Caldwell,  H.M. Arthur,  C. Demers, 
  • Page: 34
  • First Published: 20 July 2007
Free Access

132 How to do prevention in immigrant women

M. Hochleitner,  A. Bader,  F. Sahin,  H. Bezirkan, 
  • Page: 34
  • First Published: 20 July 2007
Free Access

133 Gender difference in congestive heart failure symptoms

D. Catalano,  G. Trovato,  A. Tonzuso,  D. Spadaro,  G. Martines,  M. Interrigi,  G. Garufi, 
  • Page: 34
  • First Published: 20 July 2007
Free Access

134 Heart-failure related emotional distress is associated with increased IL-6 in patients with mild to moderate heart failure

A. O'Donovan,  E. Abulhul,  C. O'Loughlin,  C. Conlon,  P. Spiers,  M. Ledwidge,  K.M. Malone,  K. McDonald, 
  • Page: 35
  • First Published: 20 July 2007
Free Access

199 Suppressors of hypertrophy in concentric and eccentric hypertrophy and upon the transition to failure

K. Lemmens,  V.F.M. Segers,  M. Demolder,  M. Michiels,  P. Muylaert,  E. De Worm,  P. Van Cauwelaert,  G.W. De Keulenaer, 
  • Page: 36
  • First Published: 20 July 2007
Free Access

200 Cardiac function and efficiency are dependent on FFA availability in patients with idiopathic dilated cardiomyopathy

H. Tuunanen,  E. Engblom,  L. Opie,  B. Hesse,  J. Airaksinen,  P. Nuutila,  H. Ukkonen,  J. Knuuti, 
  • Pages: 36-37
  • First Published: 20 July 2007
Free Access

201 Changing proportion of patients with dilated cardiomyopathy with SCDHeFT and CARE-HF/Companion characteristics during follow-up on optimal medical treatment

M. Zecchin,  A. Di Lenarda,  M. Merlo,  A. Pivetta,  D. Gregori,  D. Chicco,  F. Brun,  G.F. Sinagra,  on behalf of The Heart Muscle Disease Registry , 
  • Page: 37
  • First Published: 20 July 2007
Free Access

202 Direct arrhythmogenic effects of angiotensin II and endothelin-1 in human atrial myocardium from patients with sinus rhythm

J. Kockskaemper,  S.-U. Ruebertus,  E. Sigirci,  B. Pieske, 
  • Page: 37
  • First Published: 20 July 2007
Free Access

203 Withdrawn Adiponectin attenuates angiotensin II-induced hypertrophy by inhibiting the c-Raf-ERK1/2 pathway via Akt activation

D.J. Choi,  M.C. Choi,  E.-S. Jeon,  J.J. Kim,  G.H. Ryu, 
  • Pages: 37-38
  • First Published: 20 July 2007
Free Access

204 NT-pro BNP evaluation as a non-invasive marker of rejection after heart transplantation

M. Knazeje,  I. Malek,  M. Kment,  B. Raska,  J. Pirk, 
  • Page: 38
  • First Published: 20 July 2007
Free Access

205 Thymoglobuline administered early after heart transplantation (OHT) protects myocardial hypertrophy assessed by karyometric studies

M.W. Zakliczynski,  J. Nozynski,  E. Zembala-Nozynska,  D. Konecka-Mrowka,  M. Zembala, 
  • Page: 38
  • First Published: 20 July 2007
Free Access

206 Marginal heart donors for marginal recipients of combined heart and lung transplantation: Case reports

T. Ben Gal,  M. Kramer,  A. Kogan,  R. Michovitch,  I. Backal,  V. Yaari,  A. Battler,  G. Sahar, 
  • Pages: 38-39
  • First Published: 20 July 2007
Free Access

207 Predictors of mortality for Chagas' disease patients on the waiting list for heart transplantation

R. Bestetti,  T.A. Theodoropoulos,  J.A. Cordeiro,  D. Villafanha, 
  • Page: 39
  • First Published: 20 July 2007
Free Access

208 Quilty effect occurs in heart transplant recipients with higher risk of significant cellular rejection development

M.W. Zakliczynski,  D. Konecka-Mrowka,  J. Nozynski,  M. Swierad,  M. Zembala, 
  • Page: 39
  • First Published: 20 July 2007
Free Access

209 Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation

Y. Lin,  C. Liu,  R. Hsu,  C. Lee,  S. Wang,  Y.-L. Ho, 
  • Page: 39
  • First Published: 20 July 2007
Free Access

210 Efficacy and safety of Mycophenolate Mofetil in Chagas' heart transplant recipients

R. Bestetti,  T.A. Theodoropoulos,  T.R. Souza,  M.F. Lima,  E.A. Burdmann,  V.C. Rodrigues,  J.A. Cordeiro, 
  • Page: 40
  • First Published: 20 July 2007
Free Access

211 Investigation for correlation interrelationship between neurovegetative regulation state & psychoemotional status & cognitive functions in CHF pts before cardiosurgical myocardial revascularization

S. Komissarova,  M. Petrovskaya, 
  • Page: 40
  • First Published: 20 July 2007
Free Access

212 Plasma NT pro BNP levels do not normalize up to one year after orthotopic heart transplantation

M. Sobieszczanska-Malek,  T. Zielinski,  A. Browarek,  M. Piotrowska,  J. Korewicki, 
  • Page: 40
  • First Published: 20 July 2007
Free Access

213 Analysis of the pharmacological effects on immune cell functions: a complementary tool to therapeutic drug monitoring

M.J. Barten,  J. Garbade,  H.B. Bittner,  S. Dhein,  F.W. Mohr,  J.F. Gummert, 
  • Pages: 40-41
  • First Published: 20 July 2007
Free Access

214 Is an exercise valuable to achieve standardized NT-proBNP measurement in the heart transplant candidates?

M.W. Zakliczynski,  M. Lizak,  A. Krynicka,  J. Korewicki,  P. Przybylowski,  M. Zembala, 
  • Page: 41
  • First Published: 20 July 2007
Free Access

215 Peripheral vascular function does not predict long term survival after heart transplantation

T. Holm,  A.K. Andreassen,  S. Simonsen,  L. Gullestad, 
  • Page: 41
  • First Published: 20 July 2007
Free Access

216 Ultrastructural findings in porcine hearts during development of a new model of extracorporal long term preservation with a modified Langendorff system

H. Aupperle,  J. Garbade,  C. Ullmann,  C. Krautz,  S. Dhein,  H.A. Schoon,  F.J. Gummert, 
  • Pages: 41-42
  • First Published: 20 July 2007
Free Access

217 The prediction of cardiovascular event using FDG PET in patients with severe ischaemic left ventricular dysfunction

M. Feola,  G.L. Rosso,  G. Leonardi,  S. Peano,  A. Bianchi,  F. Rolfo,  A. Biggi,  E. Uslenghi, 
  • Page: 42
  • First Published: 20 July 2007
Free Access

218 Effects of trimetazidine and mildronat on myocardial perfusion, metabolism and left ventricular function in patients with ischemic heart failure

Y. Vasyuk,  A. Hadzegova,  E. Iouchtchouk,  E. Shkolnik,  M. Vahromeeva,  N. Vitko, 
  • Page: 42
  • First Published: 20 July 2007
Free Access

219 Validation of delayed enhancement magnetic resonance imaging by pathology in endomyocardial fibrosis patients

V.M.C. Salemi,  S.A. Oliveira,  F. Fernandes,  F.J.A. Ramires,  B.M. Ianni,  E. Arteaga,  C. Mady, 
  • Page: 43
  • First Published: 20 July 2007
Free Access

220 Correlation of myocardial function, iron overload and ergospirometry in a thalassemic population with heart failure

S. Mavrogeni,  E. Berdousis,  V. Ladis,  D. Tsiapras,  I. Paraskevaidis,  E. Gotsis,  D.V. Cokkinos,  D. Kremastinos, 
  • Page: 43
  • First Published: 20 July 2007
Free Access

221 Comparison of cardiac sympathetic nerve dysfunction as predictors of prognosis in diabetic cardiomyopathy in both insulin and non-insulin diabetcs

I. Samuil,  S. Mizuo,  M. Hana, 
  • Page: 43
  • First Published: 20 July 2007
Free Access

222 Prevalence and patterns of delayed enhanced cardiac MRI in ischemic and non ischemic cardiomyopaties

M. Nadal,  F. Ridocci Soriano,  C.J. Navarro,  J. Estornell,  M. Gudin,  A. Laynez,  R. Romaguera,  R. Paya, 
  • Pages: 43-44
  • First Published: 20 July 2007
Free Access

223 Multislice computed tomography for the diagnosis of left ventricular noncompaction

D. Boulmier,  C. Guenard-Lecompte,  J.F. Heautot,  M. Garreau,  C. Chabanne,  H. Le Breton, 
  • Page: 44
  • First Published: 20 July 2007
Free Access

224 Remote controlled robot to perform real-time echocardiography - the diagnostic future for patients in rural areas?

M. Olofsson,  K. Boman, 
  • Page: 44
  • First Published: 20 July 2007
Free Access

225 Real time quantification of coronary artery bypass graft patency by dynamic infrared imaging - an experimental study

J. Garbade,  C. Ullmann,  M.J. Barten,  M. Hollenstein,  T. Walther,  J.F. Gummert,  V. Falk,  F.W. Mohr, 
  • Pages: 44-45
  • First Published: 20 July 2007
Free Access

226 NT-proBNP level and left ventricular function in patients with acute anterior myocardial infarction treated with primary PCI

K. Wita,  A. Gerber,  A. Filipecki,  J. Myszor,  J. Krauze,  Z. Tabor,  M. Turski,  M. Trusz-Gluza, 
  • Page: 45
  • First Published: 20 July 2007
Free Access

227 Left atrial diameter in patients with heart failure: is its predictive prognostic value influenced by the etiology of heart failure?

E. Zamora,  J. Lupon Roses,  A. Urrutia,  B. Gonzalez,  A. Wilke,  S. Altimir,  C. Diez,  V. Valle, 
  • Page: 45
  • First Published: 20 July 2007
Free Access

228 Cardiac damage in the advanced phase of systemic sclerosis evolves differently in diffuse and limited disease forms: an echocardiographic study

I. Moyssakis,  E. Gialafos,  V. Vasiliou,  M. Daskalaki,  D. Papadopoulos,  P. Sfikakis,  V. Votteas, 
  • Page: 45
  • First Published: 20 July 2007
Free Access

229 2D strain imaging as a new modality to determine dyssynchronous myocardial contraction

N.J. Artis,  D.L. Oxborough,  G. Williams,  L.B. Tan,  C.B. Pepper, 
  • Page: 46
  • First Published: 20 July 2007
Free Access

230 N-terminal pro brain natriuretic peptide plasma levels show better relationship with end-diastolic than with end-systolic wall stress in heart failure patients irrespective of the etiology

R. Cortes,  M. Rivera Otero,  V. Miro,  R. Valero,  V. Climent,  V. Mora,  F. Garcia de Burgos,  R. Paya, 
  • Page: 46
  • First Published: 20 July 2007
Free Access

231 Augmentation of left ventricular longitudinal systolic and diastolic function during exercise is blunted in patients with hypertrophic cardiomyopathy

J.-W. Ha,  E.Y. Choi,  J.A. Ahn,  J.M. Kim,  S.W. Lee,  S.J. Rim,  N. Chung, 
  • Pages: 46-47
  • First Published: 20 July 2007
Free Access

232 Echocardiographic assessment of left ventricle function in children with scleromyositis

A. Borowiec-Kocanda,  J. Wozniak,  B. Firek,  M. Kwiatkowska,  R. Dabrowski,  E. Musiej-Nowakowska,  I. Kowalik,  H. Szwed, 
  • Page: 47
  • First Published: 20 July 2007
Free Access

233 Comprehensive evaluation of right ventricular performance by tissue Doppler echocardiography in first acute myocardial infarction. The role of ventricular interdependence

H. Badran,  A.K. Mostafa,  S. Shalaby,  W. Faried,  H. Hassan,  N. Faheem, 
  • Page: 47
  • First Published: 20 July 2007
Free Access

234 Echocardiographic optimisation of the VV interval improves stroke volume and synchrony in patients with resynchronisation therapy

T. Winter, 
  • Page: 47
  • First Published: 20 July 2007
Free Access

235 E/Vp is related to the functional class in a population with dyspnea

M. Rivera Otero,  L. Mainar,  M.J. Sancho Tello,  E. Rosello,  V. Climent,  A. Jordan,  V. Mora,  J.L. Diago, 
  • Pages: 47-48
  • First Published: 20 July 2007
Free Access

236 Left ventricular filling pressure as a determinant of exercise capacity in subjects with normal systolic function

J.-W. Ha,  E.Y. Choi,  J.M. Kim,  J.A. Ahn,  S.W. Lee,  S.J. Rim,  Y.S. Jang,  N. Chung, 
  • Page: 48
  • First Published: 20 July 2007
Free Access

237 Prognostic value of discharge NT-proBNP level for major adverse cardiac events in patients treated with primary PCI

K. Wita,  A. Filipecki,  K. Szydlo,  A. Gerber,  J. Krauze,  Z. Tabor,  M. Trusz-Gluza, 
  • Page: 48
  • First Published: 20 July 2007
Free Access

238 can echocardiographic early screening detect the doxorubicin induced cardiotoxicity?

T. Fulop,  I. Hegedus,  I. Edes,  K. Barta,  I. Lorincz, 
  • Pages: 48-49
  • First Published: 20 July 2007
Free Access

239 Left ventricular function improvement and left ventricular remodeling in patients with acute myocardial infarction treated with PTCA

K. Wita,  M. Turski,  A. Gerber,  M. Rybicka,  Z. Tabor,  M. Nowak,  J. Szczogiel,  M. Trusz-Gluza, 
  • Page: 49
  • First Published: 20 July 2007
Free Access

240 Assessment of prognosis of congestive heart failure secondary to silent acute myocardial infarction in type I diabetics

I. Samuil,  S. Mizuo,  M. Hiro, 
  • Page: 49
  • First Published: 20 July 2007
Free Access

241 The role of ischemic mitral regurgitation in the development of heart failure following acute myocardial infarction

D. Aronson,  R. Zuckerman,  D. Mutlak,  J. Lessick,  S. Reisner,  Y. Agmon, 
  • Pages: 49-50
  • First Published: 20 July 2007
Free Access

242 Single-beat 3D tissue synchronization imaging is a powerful technique to predict reverse left ventricular remodeling after cardiac resynchronization therapy

L. Badano,  D. Miani,  M. Baldassi,  D. Facchin,  A. Proclemer,  M.C. Albanese,  P. Gianfana,  P.M. Fioretti, 
  • Page: 50
  • First Published: 20 July 2007
Free Access

243 Reversible cardiac abnormalities after octreotide administration in acromegalic patients

C. Lafaras, 
  • Page: 50
  • First Published: 20 July 2007
Free Access

244 Functional and structural echocardiographic changes in heart failure depending of the type of failure and its impact on functional capacity

F. Baborski,  I. Scuric,  D. Cerovec,  L. Fort,  M. Majsec, 
  • Pages: 50-51
  • First Published: 20 July 2007
Free Access

245 NT-proBNP diagnostic value for diagnosis of isolated diastolic LV dysfunction in ischemic heart disease

K. Wita,  A. Filipecki,  Z. Tabor,  W. Wrobel,  M. Nowak,  M. Turski,  M. Trusz-Gluza, 
  • Page: 51
  • First Published: 20 July 2007
Free Access

246 Can we prevent atrial fibrillation following surgical revascularization?

M. Banach,  R. Irzmanski,  M. Barylski,  M. Misztal,  J. Rysz,  J. Drozdz,  P. Okonski,  J. Zaslonka, 
  • Page: 51
  • First Published: 20 July 2007
Free Access

247 Postoperative mortality and preoperative atrial fibrillation, is there a significant link?

M. Banach,  J. Drozdz,  R. Irzmanski,  M. Barylski,  J. Rysz,  P. Okonski,  J. Kowalski,  J. Zaslonka, 
  • Pages: 51-52
  • First Published: 20 July 2007
Free Access

248 Down-regulated cardiac annexin VI mRNA and protein levels in chronically fibrillating human atria

K.-C. Ueng,  H.I. Yeh,  S.A. Chen, 
  • Page: 52
  • First Published: 20 July 2007
Free Access

249 Cardiac resynchronization therapy in patients with atrial fibrillation — a meta-analysis

C. Bonanno,  R. Ometto,  M. Paccanaro,  L. La Vecchia,  A. Fontanelli, 
  • Page: 52
  • First Published: 20 July 2007
Free Access

250 Long-term incidence of atrial fibrillation in patients after heart transplantation

P. Hlivak,  M. Luknar,  J. Fabian,  R. Hatala, 
  • Page: 53
  • First Published: 20 July 2007
Free Access

251 Increased cytokine expression in adipose tissue and blood cells of heart failure patients with atrial fibrillation

A. Aleksova,  A. Bosutti,  M. Zecchin,  G. Grassi,  A. Di Lenarda,  G. Biolo,  G. Guarnieri,  G.F. Sinagra, 
  • Page: 53
  • First Published: 20 July 2007
Free Access

252 Validity of systolic myocardial strain rate for assessment of left ventricular contractility in children with isolated ventricular septal defect and congestive heart failure

A.M.A. Hegazy,  B.A. Abdulkader, 
  • Page: 53
  • First Published: 20 July 2007
Free Access

253 Exercise capacity and quality of life in patients after transcatheter closure of atrial septal defect

M. Pieculewicz,  P. Podolec,  T. Przewlocki,  L. Tomkiewicz-Pajak,  M. Hlawaty,  P. Wilkolek,  E. Suchon,  W. Tracz, 
  • Page: 54
  • First Published: 20 July 2007
Free Access

254 Cardiopulmonary exercise test for the evaluation of exercise capacity and BNP levels in adult patients after surgical repair of coarctation of aorta

O. Trojnarska,  M. Lanocha,  A. Gwizdala,  A. Katarzynska,  Z. Oko-Sarnowska,  A. Szyszka,  E. Chmara, 
  • Page: 54
  • First Published: 20 July 2007
Free Access

255 Cardiopulmonary exercise test for evaluation of exercise capacity of adults after surgical repair of coarctation of the aorta

O. Trojnarska,  M. Lanocha,  A. Katarzynska,  A. Gwizdala,  Z. Oko-Sarnowska,  A. Szyszka, 
  • Pages: 54-55
  • First Published: 20 July 2007
Free Access

256 Heterogeneity of patent foramen ovale and its causal/accidental role in cryptogenic stroke: a transesophageal echocardiographic study

D. Castagno,  R. Saviolo,  M. Anselmino,  G.P. Trevi, 
  • Page: 55
  • First Published: 20 July 2007
Free Access

257 Mid-regional pro-adrenomedullin as a novel and prognostic marker in chronic heart failure (CHF)

S. Von Haehling,  E.A. Jankowska,  N. Morgenthaler,  P. Rozentryt,  W. Doehner,  P. Ponikowski,  A. Bergmann,  S.D. Anker, 
  • Page: 55
  • First Published: 20 July 2007
Free Access

258 Heart and thyroid status in MASS-phenotype adolescents

Y.I. Strojev,  L.P. Churilov,  S.A. Sadov,  L.V. Solovjova,  O.M. Mudzhikova,  P.A. Yurchenko,  on behalf of Dept. of Pathology School of Medicine, State University , 
  • Pages: 55-56
  • First Published: 20 July 2007
Free Access

259 Thyroid hormones in chronic heart failure outpatients

A. Barison,  L. Rondinini,  S. Guideri,  M. Coceani,  M. Scarlattini,  G. Iervasi,  A. L'Abbate,  R. Mariotti, 
  • Page: 56
  • First Published: 20 July 2007
Free Access

260 Urotensin II as a novel neurohumoral modulator of diastolic function

A.P. Fontes-Sousa,  C. Bras-Silva,  D. Monteiro-Sousa,  A. Leite-Moreira, 
  • Page: 56
  • First Published: 20 July 2007
Free Access

261 Impaired systolic and diastolic myocardial response to ET-1 and Ang II in heart failure

C. Bras-Silva,  P.M. Castro-Chaves,  A.P. Fontes-Sousa,  P. Nunes,  D. Monteiro-Sousa,  A.J. Duarte,  A. Leite-Moreira, 
  • Pages: 56-57
  • First Published: 20 July 2007
Free Access

262 Levosimendan therapy in decompensated chronic heart failure: Duration of neurohormonal activation

G. Giannoglou,  G. Giannakoulas,  K. Martiadou,  A. Xanthis,  V. Vassilikos,  C. Girasis,  G. Parcharidis,  G. Louridas, 
  • Page: 57
  • First Published: 20 July 2007
Free Access

263 Does LXR-alpha connect cholesterol to the renin angiotensin system?

R.A. De Boer,  I. Kuipers,  L. van Genne,  P. van der Harst,  B. Westendorp,  D.J. van Veldhuisen,  W.H. van Gilst, 
  • Page: 57
  • First Published: 20 July 2007
Free Access

264 Melusin gene expression in the heart: The role of mechanical load and hypertrophic agonists

J. Aro,  J. Rysa,  H. Tokola,  V.-P. Ronkainen,  J. Puhakka,  M. Ilves,  I. Szokodi,  H. Ruskoaho, 
  • Page: 58
  • First Published: 20 July 2007
Free Access

265 Diastolic blood pressure and total mortality in older hypertensive patients. Results of HY-OLDEST study

L. Lambertucci,  G. Pepe,  A. Fedeli,  E. Mannucci,  M. Monami,  N. Marchionni,  G. Masotti,  A. Ungar, 
  • Page: 58
  • First Published: 20 July 2007
Free Access

266 Left atrial function in hypertensive patients with left ventricular diastolic dysfunction

A.M. Iliesiu,  C. Nicolae,  T. Nanea,  C. Campeanu, 
  • Page: 58
  • First Published: 20 July 2007
Free Access

267 Remission of heart failure: Return to normal left ventricular systolic function in optimally treated heart failure patients

N.F. Murphy,  C. O'Loughlin,  C. Conlon,  M. Ledwidge,  K. McDonald, 
  • Page: 59
  • First Published: 20 July 2007
Free Access

268 Influence of obesity on left ventricle function during 6 months follow-up after acute myocardial infarction treated by primary PCI

K. Stopyra,  A.Z. Pietrucha,  M. Misztal,  A. Gackowski,  M. Bobrowska-Juszczuk,  A. Paradowski,  D. Mroczek-Czernecka,  W. Piwowarska, 
  • Page: 59
  • First Published: 20 July 2007
Free Access

269 Systolic and systo-diastolic function evaluated by Tei index in acute myocardial infarction after acute reperfusion therapy - early and late evaluation

L. Rocha Lopes,  I. Joao,  H. Vinhas,  O. Simoes,  C. Cotrim,  C. Catarino,  M. Carrageta, 
  • Pages: 59-60
  • First Published: 20 July 2007
Free Access

270 3DRTE and TDI left ventricular mechanical dyssynchrony indexes: analysis in four groups of patients

E. Saloux,  P. Pon Gabrielsen,  P. Allain,  O. Gerard,  F. Labombarda,  A. Pelissier, 
  • Page: 60
  • First Published: 20 July 2007
Free Access

271 Left ventricular remodelling: comparison of 2D and 3D sphericity index in 2 patient groups

E. Saloux,  P. Pon Gabrielsen,  P. Allain,  O. Gerard,  A. Pelissier,  F. Labombarda, 
  • Page: 60
  • First Published: 20 July 2007
Free Access

272 Chronotropic effect of cilostazol on left ventricular function after acute myocardial infarction

S.H. Lee,  J.H. Jung,  S.H. Choi,  N. Lee,  G.Y. Cho,  D.J. Oh,  C.Y. Rhim,  K.H. Lee, 
  • Page: 60
  • First Published: 20 July 2007
Free Access

273 Correlation between longitudinal systolic function of the left ventricle and the “non-velocity-type” parameters characterizing left ventricular diastolic function

R. Faludi,  L. Toth,  E. Fodi,  G. Kolto,  B. Gyomorei,  T. Simor,  L. Papp, 
  • Page: 61
  • First Published: 20 July 2007
Free Access

274 A marker of early ventricular dysfunction in rheumatoid arthritis patients

S. Abou-Raya,  A. Abou-Raya,  A. Naim, 
  • Page: 61
  • First Published: 20 July 2007
Free Access

275 Does systolic function determine the prognosis of hospitalized patients due to worsening heart failure?

A. Goncalves,  A. Azevedo,  R. Almeida,  J. Mascarenhas,  M. Patacho,  F. Rocha-Goncalves,  P. Bettencourt, 
  • Pages: 61-62
  • First Published: 20 July 2007
Free Access

276 Expression of extracellular matrix (ECM) proteins and matrix metalloproteinases in end-stage dilated, ischemic or valvular cardiomyopathies

P.A. Schnabel,  E. Herpel,  M. Pritsch,  A. Koch,  T.J. Dengler,  P. Schirmacher, 
  • Page: 62
  • First Published: 20 July 2007
Free Access

277 Changes of plasma NT-proBNP level can predict changes of echocardiographic variables after medical treatment in hypertrophic cardiomyopathy with normal ejection fraction

E.-S. Jeon,  S.C. Lee,  S.W. Park,  D.K. Kim,  S.H. Lee,  M.C. Cho,  K.H. Ryu,  D.J. Choi, 
  • Page: 62
  • First Published: 20 July 2007
Free Access

278 Profile of the anti-Parvovirus B19 humoral response in patients with clinically suspected acute myocarditis, chronic myocarditis and dilated cardiomyopathy

F. Escher,  M. Noutsias,  U. Kuehl,  M. Paschinger,  D. Lassner,  H.-P. Schultheiss,  S. Modrow, 
  • Pages: 62-63
  • First Published: 20 July 2007
Free Access

279 Cell determinants of myocardial dysfunction in fabry disease cardiomyopathy

C. Chimenti,  N. Hamdani,  M. Pieroni,  J. van der Velden,  G.J.M. Stienen,  C. Gaudio,  W. Paulus,  A. Frustaci, 
  • Page: 63
  • First Published: 20 July 2007
Free Access

280 Diabetes cardiomiopathy in diabetic patients without co-morbidities

L. Mendes,  J. Ferreira Santos,  L. Pinto,  F. Caetano,  F. Seixo,  F. Martins,  P. Cardoso,  M. Mendes, 
  • Page: 63
  • First Published: 20 July 2007
Free Access

281 Anthracycline-induced cardiomyopathy: characteristics and outcome

L. Massa,  E. Viel,  C. Lestuzzi,  A. Di Lenarda,  L. Tartuferi,  B. Pinamonti,  N. Meneguzzo,  G.F. Sinagra, 
  • Pages: 63-64
  • First Published: 20 July 2007
Free Access

282 Left ventricular end diastolic pressure — a marker for serious arrhythmic events and sudden cardiac death in hypertrophic cardimyopathy

Z. Oko-Sarnowska,  H. Wachowiak-Baszynska,  A. Katarzynska,  O. Trojnarska,  A. Szyszka,  J. Jankowski,  E. Chmara,  R. Ochotny, 
  • Page: 64
  • First Published: 20 July 2007
Free Access

283 Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy

M. Luedde,  M. Knorr,  H.J. Hippe,  B. Brors,  H.A. Katus,  N. Frey, 
  • Page: 64
  • First Published: 20 July 2007
Free Access

284 The incremental prognostic significance of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study

A. Di Lenarda,  B. Pinamonti,  D. Gregori,  G. Nucifora,  A. Perkan,  A. Aleksova,  M. Merlo,  G.F. Sinagra,  on behalf of The Heart Muscle Disease Registry , 
  • Page: 65
  • First Published: 20 July 2007
Free Access

285 The changing phenotypic expression of hypertrophic cardiomyopathy throughout life. Insights from a genotyped population with a long follow-up

D. Brito,  P. Marques-Vidal,  P. Richard,  M. Komajda,  H. Madeira, 
  • Page: 65
  • First Published: 20 July 2007
Free Access

286 Familial and sporadic hypertrophic cardiomyopathy: differences and similarities in a genotyped population. A follow-up study

D. Brito,  P. Marques-Vidal,  P. Richard,  M. Komajda,  H. Madeira, 
  • Pages: 65-66
  • First Published: 20 July 2007
Free Access

287 Novel mutation in the TCAP gene encoding titin-cap/telethonin in a family with hypertrophic cardiomyopathy

A. Perrot,  M.G. Posch,  C. Geier,  K.J. Osterziel, 
  • Page: 66
  • First Published: 20 July 2007
Free Access

288 Heart-rate dependent prolongation of QRS duration time in patients with hypertrophic cardiomyopathy does not correlate with the degree of left ventricle hypertrophy or the diastolic dysfunction

H. Wachowiak-Baszynska,  Z. Oko-Sarnowska,  A. Katarzynska,  E. Straburzynska-Migaj,  P. Mitkowski,  R. Ochotny,  O. Trojnarska,  J. Jankowski, 
  • Page: 66
  • First Published: 20 July 2007
Free Access

289 Percutaneous septal ablation for hypertrophic obstructive cardiomyopathy: What characterizes patients with cardiac events during long-term follow-up?

L. Faber,  D. Welge,  D. Fassbender,  H.K. Schmidt,  D. Horstkotte,  U. Gleichmann,  H. Seggewiss, 
  • Pages: 66-67
  • First Published: 20 July 2007
Free Access

290 Longitudinal evaluation of cardiac growth in newborns of well controlled diabetic mothers

A. Jurko Jr.,  A. Jurko,  D. Mesko, 
  • Page: 67
  • First Published: 20 July 2007
Free Access

291 Clinical and morphological characteristics of patients with dilated cardiomyopathy caused by mutations in the LMNA gene

Z.T. Bilinska,  N. Sylvius,  J. Grzybowski,  A. Fidzianska,  E. Michalak,  E. Walczak,  F. Tesson,  W. Ruzyllo, 
  • Page: 67
  • First Published: 20 July 2007
Free Access

292 Factors associated with increased risk of sudden death in patients with idiopathic dilated cardiomyopathy

A. Di Lenarda,  M. Merlo,  A. Aleksova,  A. Pivetta,  F. Brun,  D. Chicco,  R. Bussani,  G. Sinagra,  on behalf of The Heart Muscle Disease Registry , 
  • Page: 67
  • First Published: 20 July 2007
Free Access

293 Prevalence of organ specific autoantibodies (anti-human-tissue-transglutaminase, anti-endomysial, anti-actin and anti-thyreoperoxidasis antibodies) in dcm patients and their relatives

A. Di Lenarda,  D. Chicco,  A. Taddio,  L. Rubert,  M. Moretti,  E. Fabbro,  G.F. Sinagra,  T. Not, 
  • Page: 68
  • First Published: 20 July 2007
Free Access

294 Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy

K. Miettinen,  S. Eriksson,  J. Magga,  P. Tuomainen,  E. Vanninen,  K. Punnonen,  K. Pettersson,  K. Peuhkurinen, 
  • Page: 68
  • First Published: 20 July 2007
Free Access

295 Nuclear changes and expression of lamins A and C in dilated cardiomyopathy

R. Cortes,  M. Portoles,  L. Almenar,  L. Martinez Dolz,  V. Miro,  A. Salvador,  V. Bertomeu,  M. Rivera Otero, 
  • Pages: 68-69
  • First Published: 20 July 2007
Free Access

296 Exercise induced increase of lipid peroxidation in patients with chronic heart failure: relation to exercise intolerance

N. Sayar,  H. Yilmaz,  S. Terzi,  N. Cakmak,  B. Tangurek,  F. Ciloglu,  I. Peker,  K. Yesilcimen, 
  • Page: 69
  • First Published: 20 July 2007
Free Access

297 The type of heart failure and its effects on endothelial function and inflammatory process: differences between ischemic and dilated heart failure

C. Antoniades,  D. Tousoulis,  M. Kotsopoulou,  K. Marinou,  C. Tentolouris,  G. Siasos,  E. Stefanadi,  C. Stefanadis, 
  • Page: 69
  • First Published: 20 July 2007
Free Access

298 Mitral valve repair is the key in surgical treatment of primary dilated cardiomyopathy with heart failure

N. Radovanovic,  B. Mihajlovic,  S. Nicin,  Z. Jonjev,  L. Petrovic,  M. Fabri,  S. Susak,  M. Zorc, 
  • Page: 69
  • First Published: 20 July 2007
Free Access

299 Autonomic and endothelial interaction with functional capacity in patients with dilated cardiomyopathy and optimal neuro-humoral treatment

W. Grander,  P. Eller,  M. Stuehlinger,  D. Flotzinger,  G. Djuras,  P. Groechenig,  W. Dichtl,  H. Tilg, 
  • Page: 70
  • First Published: 20 July 2007
Free Access

300 Distribution of Beta 1 and Beta 2 adrenergic receptor polymorphisms and susceptibility to idiopathic dilated cardiomyopathy in Polish population

A. Paczkowska,  Z.T. Bilinska,  M. Szperl,  J. Grzybowski,  M. Roszczynko,  L. Mazurkiewicz,  W. Piotrowski,  W. Ruzyllo, 
  • Page: 70
  • First Published: 20 July 2007
Free Access

301 Withdrawn Evaluation of mechanical dyssynchrony in dilated cardiomyopathy: Idiopathic versus noncompaction of left ventricle

M. Moshkani Farahani,  M. Esmaeil Zadeh,  A. Bagher Zadeh, 
  • Pages: 70-71
  • First Published: 20 July 2007
Free Access

302 Clinical aspects of familial dilated cardiomyopathy — the Berlin experience

M.G. Posch,  A. Perrot,  S. Hassfeld,  H.B. Lehmkuhl,  R. Hetzer,  K.J. Osterziel, 
  • Page: 71
  • First Published: 20 July 2007
Free Access

303 The effect of FFA betaoxidation inhibition on myocardial metabolism and function in patients with idiopathic dilated cardiomyopathy

H. Tuunanen,  E. Engblom,  L. Opie,  B. Hesse,  J. Airaksinen,  P. Iozzo,  H. Ukkonen,  J. Knuuti, 
  • Page: 71
  • First Published: 20 July 2007
Free Access

304 A combination of single nucleotide polymorphisms of the human cardiac ryanodine receptor (RyR2) is associated with arrhythmogenic right ventricular cardiomyopathy

H. Milting,  B. Klauke,  A. Perrot,  K.J. Osterziel,  J. Vogt,  S. Peters,  R. Thieleczek,  M. Varsanyi, 
  • Pages: 71-72
  • First Published: 20 July 2007
Free Access

345 Endothelial dysfunction by genetic deletion or inhibition of the G protein-coupled receptor Mas - a new target to improve endothelial function

T. Walther,  S. Vallejo,  C. Sanchez-Ferrer,  S. Heringer-Walther,  V. Azcutia,  L. Rodriguez-Manas,  F. Gembardt,  C. Peiro, 
  • Page: 73
  • First Published: 20 July 2007
Free Access

346 Tissue Doppler Echocardiography for the estimation of left ventricular systolic function in patients with heart failure and normal ejection fraction

M. Michalski,  M. Kandziora,  W. Biegalski,  R. Dankowski,  A. Piatkowska,  M. Wierzchowiecki,  K. Poprawski, 
  • Page: 73
  • First Published: 20 July 2007
Free Access

347 Angiotensin II-induced increase in myocardial distensibility is modulated by the endocardial endothelium and endothelin-1

P.M. Castro-Chaves,  A. Lima-Carneiro,  P. Pimentel-Nunes,  R. Fontes-Carvalho,  A. Leite-Moreira, 
  • Pages: 73-74
  • First Published: 20 July 2007
Free Access

348 NO and prostaglandins are required for the increase in myocardial distensibility induced by ET-1

C. Bras-Silva,  D. Monteiro-Sousa,  A.J. Duarte,  A.P. Fontes-Sousa,  A. Leite-Moreira, 
  • Page: 74
  • First Published: 20 July 2007
Free Access

349 Improving the utility and cost-effectiveness of NT-proBNP for the screening of patients considered at high risk of left ventricular systolic dysfunction in primary care

K. Goode,  A.L. Clark,  J.A. Bristow,  K.B. Sykes,  J.G.F. Cleland, 
  • Page: 74
  • First Published: 20 July 2007
Free Access

350 Oscillatory ventilation during exercise: independent predictor of increased mortality in patients with stable chronic heart failure

T. Witkowski,  K. Nowak,  E.A. Jankowska,  A. Grzeslo,  J. Petruk-Kowalczyk,  W. Banasiak,  P. Ponikowski, 
  • Page: 75
  • First Published: 20 July 2007
Free Access

351 Systemic activation of skeletal muscle ergoreceptors is associated with the progression of the syndrome of chronic heart failure

M.F. Piepoli,  A. Kaczmarek,  D.P. Francis,  L.C. Davies,  A. Capucci,  S.D. Anker,  W. Banasiak,  P. Ponikowski, 
  • Page: 75
  • First Published: 20 July 2007
Free Access

352 The impact of cardiac resynchronisation therapy on systemic vascular resistance

A.Y. Patwala,  P. Woods,  D. Barker,  S.G. Williams,  D.F. Goldspink,  L.B. Tan,  D.J. Wright, 
  • Pages: 75-76
  • First Published: 20 July 2007
Free Access

353 Elevated plasma markers of matrix metalloproteinases type 2 and 9 are independent predictors of diastolic heart failure

R. Martos,  J. Baugh,  M. Ledwidge,  C. O'Loughlin,  C. Conlon,  S. Donnelly,  K. Mcdonald, 
  • Page: 76
  • First Published: 20 July 2007
Free Access

354 Repair of infarcted myocardium in patients with left ventricular dysfunction. Randomized study with intracoronary autologous mononuclear bone marrow cell transplantation in patients with acute MI

R. Panovsky,  J. Meluzin,  J. Mayer,  M. Kaminek,  L. Groch,  S. Janousek,  J. Prasek,  J. Stanicek, 
  • Page: 76
  • First Published: 20 July 2007
Free Access

355 Cardiac lesions associated with sudden death in sportsmen: effects of norethandrolone in the rabbit

Q. Timour Chah,  D. Belhani,  P. Tsibiribi,  A. Tabib,  L. Fanton,  L. Gomez,  C. Bui-Xuan,  J. Descotes, 
  • Pages: 76-77
  • First Published: 20 July 2007
Free Access

356 Changes of haemodynamics in models with subacute right ventricular pressure overload

Z. Ge,  E. Hao,  F. Li,  Y. Li,  W. Jiang,  Y. Wu,  X. Ji,  Y. Zhang, 
  • Page: 77
  • First Published: 20 July 2007
Free Access

357 Effect of chronic insulin therapy in the mitochondrial function in an ex-vivo animal model of global myocardial ischemia-reperfusion

P.F. Monteiro,  M. Paiva,  R.S. Carreira,  L.M. Goncalves,  L.A. Providencia, 
  • Page: 77
  • First Published: 20 July 2007
Free Access

358 The central interaction between angiotensin and vasopressin systems in the cardiovascular regulation after myocardial infarction

A. Cudnoch-Jedrzejewska,  J. Dobruch,  E. Szczepanska-Sadowska, 
  • Pages: 77-78
  • First Published: 20 July 2007
Free Access

359 Cardiac lesions induced by neuroleptic drugs in the rabbit

D. Belhani,  D. Frassati,  R. Megard,  Q. Timour Chah,  B. Bui-Xuan,  A. Tabibi,  L. Fanton,  J. Descotes, 
  • Page: 78
  • First Published: 20 July 2007
Free Access

360 Age-dependent changes in contractile function and passive elastic properties of myocardium of mice lacking muscle LIM protein (MLP)

B. Unsoeld,  H. Schotola,  C. Jacobshagen,  H. Koegler,  G. Hasenfuss, 
  • Page: 78
  • First Published: 20 July 2007
Free Access

361 Erythropoietin attenuates myocardial ischemic-reperfusion injury through redistribution of beta-adrenergic receptor kinase1

D.J. Choi,  E.-S. Jeon,  M.C. Cho,  J.J. Kim,  S.J. Park,  G.H. Ryu, 
  • Pages: 78-79
  • First Published: 20 July 2007
Free Access

362 Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters

M.J. Crespo,  P.I. Altieri,  N. Escobales, 
  • Page: 79
  • First Published: 20 July 2007
Free Access

363 A minimally invasive approach for efficient in-vivo gene delivery to the pig myocardium

M. Torrado,  A. Centeno,  E. Lopez,  B. Nespereira,  A. Castro-Beiras,  A.T. Mikhailov, 
  • Page: 79
  • First Published: 20 July 2007
Free Access

364 Adenosine inhibits matrix metalloproteinase-9 secretion by activated neutrophils through a cAMP/PKA/Ca2+ pathway

I. Ernens,  D. Rouy,  Y. Devaux,  C. Jeanty,  D. Wagner, 
  • Pages: 79-80
  • First Published: 20 July 2007
Free Access

365 Cardiac contractility modulation with non-excitatory electrical signals normalizes expression of the calcium-binding protein sorcin in dogs with chronic heart failure

R.C. Gupta,  S. Mishra,  S. Rastogi,  V. Zaca,  B. Rousso,  H.N. Sabbah, 
  • Page: 80
  • First Published: 20 July 2007
Free Access

366 Increased mast cells density in myocardial tissue from heart failure patients

M. Batlle,  F. Perez-Villa,  E. Garcia-Pras,  M. Roque,  J. Orus,  A. Leivas,  J. Ramirez,  E. Roig, 
  • Page: 80
  • First Published: 20 July 2007
Free Access

367 Nuclear changes and expression of lamins A and C in ischaemic cardiomyopathy

R. Cortes,  M. Portoles,  L. Martinez Dolz,  L. Almenar,  M.J. Sancho Tello,  E. Rosello,  A. Salvador,  M. Rivera Otero, 
  • Pages: 80-81
  • First Published: 20 July 2007
Free Access

368 Limited exercise capacity is related to abnormal increase in pulmonary artery pressure and right ventricular dysfunction in chronic obstructive pulmonary disease

E. Suchon,  W. Tracz,  P. Podolec,  W. Plazak,  A. Prokop,  P. Nalepa, 
  • Page: 81
  • First Published: 20 July 2007
Free Access

369 Acute recruitment of myocardial contractile reserve in heart failure patients after cardiac resynchronization therapy

W. Mullens,  J. Bartunek,  M. Goethals,  S. Verstreken,  P. Geelen,  B. De Bruyne,  H. De Raedt,  M. Vanderheyden, 
  • Page: 81
  • First Published: 20 July 2007
Free Access

370 Different methods of calculating ejection: a large correlative study

A. Gholamrezanezhad,  M. Saghari,  S. Mirpour,  M. Eftekhari, 
  • Pages: 81-82
  • First Published: 20 July 2007
Free Access

371 Possible molecular determinants of altered myocardial function during oxidative stress

Z. Hertelendi,  A. Toth,  A. Borbely,  Z. Galajda,  M. Vaszily,  I. Edes,  Z. Papp, 
  • Page: 82
  • First Published: 20 July 2007
Free Access

372 Irbesartan attenuates left ventricular dysfunction in diabetic cardiomyopathy due to inhibition of cardiac remodeling and cardiac inflammation

D. Westermann,  S. Rutschow,  A. Linderer,  A. Riad,  H.-P. Schutlheiss,  M. Pauschinger,  C. Tschope, 
  • Page: 82
  • First Published: 20 July 2007
Free Access

373 Detection of left ventricular diastolic dysfunction as a marker of early diabetic cardiomyopathy in patients with long standing diabetes

P. Reddy,  J. Dhawan,  P.H. Loh,  L. Tin,  S.F. Beer,  J. John,  A.L. Clark,  J.G.F. Cleland,  on behalf of Academic Cardiology, University of Hull , 
  • Pages: 82-83
  • First Published: 20 July 2007
Free Access

374 Ventricular filling mechanisms: study of regional pressure gradients and myocardial segmental lengths along the cardiac cycle

M.S. Guerra,  M.J. Amorim,  C. Bras-Silva,  A. Leite-Moreira, 
  • Page: 83
  • First Published: 20 July 2007
Free Access

375 Angiotensin II acutely increases ventricular distensibility

M.S. Guerra,  P.M. Castro-Chaves,  C. Bras-Silva,  A. Leite-Moreira, 
  • Page: 83
  • First Published: 20 July 2007
Free Access

376 Comparison of arterial compliance and peripheral microvascular reactivity in patients with heart failure and either preserved or reduced left ventricular systolic function

S. Balmain,  N. Padmanabhan,  W.R. Ferrell,  J.J.V. McMurray, 
  • Pages: 83-84
  • First Published: 20 July 2007
Free Access

377 Cardiac fibrosis correlates with cardiac diastolic stiffness in patients with isolated diastolic heart failure

C. Tschope,  D. Westermann,  A. Kallwellis-Opara,  M. Kasner,  F. Spillmann,  S. Liu,  H.-P. Schultheiss,  M. Pauschinger, 
  • Page: 84
  • First Published: 20 July 2007
Free Access

378 Assessment of left ventricular diastolic function in type 2 diabetic Nepalese population

P. Acharya,  N.R. Shrestha,  S.K. Sharma,  P. Karki, 
  • Page: 84
  • First Published: 20 July 2007
Free Access

379 Diabetes deteriorates diastolic function in hypertensive patients - impact of gender

R. Wachter,  C. Luers,  S. Kleta,  K. Griebel,  N. Janicke,  B. Pieske, 
  • Page: 84
  • First Published: 20 July 2007
Free Access

380 Statin therapy reduced mortality in patients with diastolic heart failure

M. Roik,  M.H. Starczewska,  S. Stawicki,  J. Kochanowski,  Z. Huczek,  G. Opolski, 
  • Page: 85
  • First Published: 20 July 2007
Free Access

381 Left ventricular diastolic dysfunction in human immunodeficiency virus infection: an echocardiography study

J. Kondratieva,  P. Krings,  K. Neuhaus,  T. Neumann,  B. Ross,  S. Esser,  R. Erbel, 
  • Page: 85
  • First Published: 20 July 2007
Free Access

382 Levosimendan improves markers of diastolic function and neurohormonal activation in patients with decompensated advanced heart failure

D. Farmakis,  J.T. Parissis,  K. Kourea,  V. Bistola,  C. Papadopoulos,  M. Nikolaou,  F. Panou,  D. Kremastinos, 
  • Pages: 85-86
  • First Published: 20 July 2007
Free Access

383 Comparison of echocardiography and natriuretic peptides (BNP) in the serial evaluation of patients with isolated diastolic left ventricular dysfunction

S. Romano,  S. Fratini,  N. Furia,  F. Calcagnoli,  V. Ciampini,  M. Penco, 
  • Page: 86
  • First Published: 20 July 2007
Free Access

384 Left ventricular diastolic dysfunction in patients with chronic obstructive pulmonary disease

E. Suchon,  W. Tracz,  P. Podolec,  W. Plazak,  A. Prokop,  P. Nalepa, 
  • Page: 86
  • First Published: 20 July 2007
Free Access

385 Value of left ventricular filling parameters to predict mortality in a sample of subjects with preserved systolic function from the general population

F. Pedersen,  I. Raymond,  D. Atar,  P. Hildebrandt, 
  • Pages: 86-87
  • First Published: 20 July 2007
Free Access

386 Correlation of diastolic flow wave patterns in the LVOT with early diastolic mitral annular velocity determined by tissue Doppler imaging

B. Hassunizadeh,  M. Freih,  S.L. Pheng,  D. Cunningham,  H. Ghanbari,  C. Machado,  B. Clark III, 
  • Page: 87
  • First Published: 20 July 2007
Free Access

387 Relation of myocardial repolarisation and conduction to diastolic function and left ventricular hypertrophy in hypertensive patients

H.-D. Duengen,  S. Fehrendt,  K. Schimpf,  R. Wachter,  B. Pieske,  R. Dietz,  K.J. Osterziel,  W. Haverkamp, 
  • Page: 87
  • First Published: 20 July 2007
Free Access

388 Correlation between diastolic dysfunction, pulmonary hypertension and BNP in patients with chronic heart failure

E. Straburzynska-Migaj,  A. Straburzynska-Lupa,  R. Ochotny,  A. Cieslinski, 
  • Pages: 87-88
  • First Published: 20 July 2007
Free Access

389 Right ventricular diastolic function abnormalities in patients with type 1 diabetes

D. Beldekos,  G. Psaltiras,  S. Handanis,  A. Lyras,  S. Argirakis,  A. Koutsovasilis,  A. Melidonis,  S.G. Foussas, 
  • Page: 88
  • First Published: 20 July 2007
Free Access

390 Diastolic function abnormalities in healthy obese women

L. Mendes,  F. Caetano,  J. Ferreira Santos,  F. Seixo,  F. Martins,  P. Cardoso,  N. Nunes,  M. Mendes, 
  • Page: 88
  • First Published: 20 July 2007
Free Access

391 Left atrial shape and surface significance for diastolic heart failure

D.C. Cozma,  L. Petrescu,  R. Dan,  D. Lighezan,  S.I. Dragulescu, 
  • Page: 88
  • First Published: 20 July 2007
Free Access

392 Clinical measures poorly predict diastolic filling

I.P. Clements,  D.O. Hodge,  S.G. Scott, 
  • Page: 89
  • First Published: 20 July 2007
Free Access

393 Is diastolic heart failure a separate entity? Demonstration of a strong interrelationship between systolic and diastolic myocardial function

M. Gaballa,  L.Å. Brodin,  J. Van der Linden,  K. O'Reilly,  L. Brudin, 
  • Page: 89
  • First Published: 20 July 2007
Free Access

394 Prevalence of isolated diastolic dysfunction in hospitalized diabetic patients: correlations according to different line treatment

G. Pumilia,  S. La Carrubba,  A. Puleo,  L. Manna,  F. Arancio,  S. Di Rosa, 
  • Pages: 89-90
  • First Published: 20 July 2007
Free Access

395 The effect of doxazosin on nocturnal orthopnea and left ventricular dysfunction in patients with congestive heart failure

A. Giuca,  A. Ungureanu,  M. Zaharie,  I. Popa,  D.-D. Ionescu, 
  • Page: 90
  • First Published: 20 July 2007
Free Access

396 Diastolic function in young patients with beta-Thalassaemia major: an echocardiographic study

C. Chrysohoou,  C. Pitsavos,  D. Panagiotakos,  C. Aggeli,  C. Kosma,  V. Ladis,  M. Karagiorga,  C. Stefanadis, 
  • Page: 90
  • First Published: 20 July 2007
Free Access

397 Heart rate variability correlates with symptoms of heart failure in patients with diastolic dysfunction

H.-D. Duengen,  K. Schimpf,  S. Fehrendt,  R. Wachter,  B. Pieske,  R. Dietz,  K.J. Osterziel,  W. Haverkamp, 
  • Pages: 90-91
  • First Published: 20 July 2007
Free Access

398 Abnormal left ventricular diastolic filling pattern in patients with hypertensive response during exercise electrocardiography test

F. Adam,  C. Caltea,  E. Ovricenco,  C. Sinescu, 
  • Page: 91
  • First Published: 20 July 2007
Free Access

399 Hypertension and prognostic value of brain natriuretic peptide in diastolic dysfunction of heart

Y. Vasyuk,  A. Hadzegova,  S. Ivanova,  I. Amirbegishvili,  N. Gerasimova,  E. Yushouk,  P. Krikunov, 
  • Page: 91
  • First Published: 20 July 2007
Free Access

400 The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients

N. Aspromonte,  M. Feola,  A. D'Eri,  F. Noventa,  A.B. Scardovi,  P. Giovinazzo,  L. Milani,  R. Valle, 
  • Pages: 91-92
  • First Published: 20 July 2007
Free Access

401 Early flow propagation for assessment of diastolic function in acute myocardial infarction after acute reperfusion - early and late evaluation

L. Rocha Lopes,  I. Joao,  H. Vinhas,  O. Simoes,  C. Cotrim,  C. Catarino,  M. Carrageta, 
  • Page: 92
  • First Published: 20 July 2007
Free Access

402 Why do heart failure patients with impaired and normal left ventricular ejection fraction die?

L. Grigorian,  A. Varela Roman,  E. Abu Assi,  R.C. Vidal Perez,  F. Otero Ravina,  J.R. Gonzalez-Juanatey, 
  • Page: 92
  • First Published: 20 July 2007
Free Access

403 High dose allopurinol dramatically improves endothelial dysfunction more than conventional doses in chronic heart failure

J. George,  A.D. Struthers, 
  • Pages: 92-93
  • First Published: 20 July 2007
Free Access

404 Conditional antisense-knockdown of zebrafish cardiac troponin C as a new model for dilated cardiomyopathy

Y. Lin,  Y.-L. Ho,  W. Tsai,  G. Wang,  F. Hsieh,  H. Tsai, 
  • Page: 93
  • First Published: 20 July 2007
Free Access

405 Increased myogenic tone in mesenteric artery in chronic heart failure involves transactivation of EGF receptor via AT1 receptor

Y. Xu,  R. Henning,  W. van Gilst,  H. Buikema, 
  • Page: 93
  • First Published: 20 July 2007
Free Access

406 Accelerated mitochondrial ATP supply prevents cardiac failure

T. Walther,  C. Tschope,  A. Sterner-Kock,  A. Riad,  Y. Wang,  S. Heringer-Walther,  H.-P. Schultheiss,  A. Dorner, 
  • Pages: 93-94
  • First Published: 20 July 2007
Free Access

407 Cardiotrophin-1 survival pathway is impaired in experimental heart failure. A role for neurohumoral activation

N. Lopez,  J. Diez,  M.A. Fortuno, 
  • Page: 94
  • First Published: 20 July 2007
Free Access

408 Cardiovascular effects and angiotensin system adaptation in experimental heart failure after aldosterone synthase inhibition

V. Mellin,  B. Di Meglio,  A.Y. Jeng,  R.L. Webb,  J.P. Henry,  C. Thuillez,  P.M. Mulder, 
  • Page: 94
  • First Published: 20 July 2007
Free Access

409 Activation of gender-specific targets in gene expression in post-MI remodeling

M. Bauer,  G. Mitterer,  W. Dietl,  K. Trescher,  E. Wolner,  W. Schmidt,  B.K. Podesser, 
  • Page: 94
  • First Published: 20 July 2007
Free Access

410 In-stent restenosis in bare metal stents and drug-eluting stents after primary stenting and stem cell transplantation for myocardial infarction: a randomised quantitative coronary angiography study

C. Steinwender,  R. Hofmann,  A. Kypta,  J. Kammler,  G. Schuster,  C. Gabriel,  F. Leisch, 
  • Page: 95
  • First Published: 20 July 2007
Free Access

411 Do macroaggregates improve the retention of autologous mononuclear bone marrow cells in recanalized coronary arteries?

J.D. Schipke,  S. Schmitz-Spanke,  T. Zeus,  B. Peter,  K. Meyer,  C. Genzel,  B.E. Strauer,  E. Gams, 
  • Page: 95
  • First Published: 20 July 2007
Free Access

412 Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure two years follow-up of the POZNAN trial

T. Siminiak,  D. Fiszer,  O. Jerzykowska,  N. Rozwadowska,  B. Grygielska,  P. Kalmucki,  M. Majewski,  M. Kurpisz, 
  • Pages: 95-96
  • First Published: 20 July 2007
Free Access

413 Autologous mononuclear bone marrow cells take part in repairing of infarcted of myocardium

V. Ryabov,  T. Suslova,  V. Markov,  U. Poponina,  A. Krylov,  S. Popov,  R. Karpov, 
  • Page: 96
  • First Published: 20 July 2007
Free Access

414 Percutaneous intracoronary cellular cardiomyoplasty for non-ischemic dilated cardiomyopathy: clinical and histopathological results. The STIC (STem cells In Cardiomyopathy) trial

S. Seth,  R. Narang,  B. Bhargava,  R. Ray,  S. Mohanty,  G. Gulati,  L. Kumar,  P. Venugopal,  on behalf of AIIMS stem cell study group for STIC trial , 
  • Page: 96
  • First Published: 20 July 2007
Free Access

415 P38 kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms

O. Tenhunen,  Y. Soini,  M. Ilves,  J. Rysa,  R. Serpi,  J. Tuukkanen,  H. Ruskoaho,  H. Leskinen, 
  • Pages: 96-97
  • First Published: 20 July 2007
Free Access

416 The Thr164Ile-beta2-adrenoceptor and heart failure

K. Leineweber,  O.-E. Brodde,  G. Heusch,  R. Koerfer, 
  • Page: 97
  • First Published: 20 July 2007
Free Access

417 Pharmacogenetic interactions between Arg389Gly Beta-1 adrenoceptor polymorphism and beta-blocker treatment in patients with heart failure

N. Pezzali,  M. Metra,  S. Nodari,  L. Covolo,  U. Gelatti,  F. Donato,  L. Dei Cas, 
  • Page: 97
  • First Published: 20 July 2007
Free Access

418 Clinical deterioration of heart failure patients is associated with gradual transcriptome modulation

G. Lamirault,  N. Le Meur,  C. Chevalier,  M.-F. Le Cunff,  I. Guisle,  J.-N. Trochu,  M. Steenman,  J.J. Leger, 
  • Pages: 97-98
  • First Published: 20 July 2007
Free Access

419 Telomere length of circulating leukocytes is decreased in patients with chronic heart failure

P. Van der Harst,  G. van der Steege,  R.A. De Boer,  A.A. Voors,  A.S. Hall,  M.J. Mulder,  W.H. van Gilst,  D.J. van Veldhuisen,  on behalf of MERIT-HF Study Group , 
  • Page: 98
  • First Published: 20 July 2007
Free Access

420 A novel SCN5A mutation (R878C) associated with sick sinus syndrome in one Chinese family

Y.M. Zhang,  A.Q. Ma,  H.M. Wan,  C. Huang,  X.H. Zhou,  R.M. Shi,  J. Gao,  on behalf of Environment and Genes Related to Diseases Key Laboratory , 
  • Page: 98
  • First Published: 20 July 2007
Free Access

421 The NFATc2 isoform plays a major role in calcineurin-induced cardiac hypertrophy

M. Bourajjaj,  A.S. Armand,  B. Weijts,  L.J. De Windt, 
  • Page: 98
  • First Published: 20 July 2007
Free Access

422 Withdrawn Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy

O. Ritter, 
  • Page: 99
  • First Published: 20 July 2007
Free Access

423 Genome wide expression profiling of NFAT transcriptional activity in a ventricular muscle cell line identifies GATA4 as an NFAT target gene in a feedforward mechanism driving cardiomyocyte hypertrophy

M. Bourajjaj,  A.S. Armand,  I.I. Rybkin,  R. Bassel-Duby,  E.N. Olson,  J.D. Molkentin,  L.J. De Windt, 
  • Page: 99
  • First Published: 20 July 2007
Free Access

424 Mobilization of CXCR4+/CD34+ stem cells early in acute myocardial infarction is correlated with left ventricular ejection fraction and NT-proBNP levels after 1 year of follow-up (MRI study)

W. Wojakowski,  R. Wyderka,  K. Maslankiewicz,  J. Ciosek A Ochala,  A. Zebzda,  P. Buszman,  M.Z. Ratajczak,  M. Tendera,  on behalf of REGENT Study Group , 
  • Pages: 99-100
  • First Published: 20 July 2007
Free Access

425 Growth hormone enhances proliferation of cardiac myocytes and induces a substantial increase in the total number of cardiac myocytes in the normal rat heart

A. Bruel,  J.R. Nyengaard, 
  • Page: 100
  • First Published: 20 July 2007
Free Access

426 Standard hemodynamic assessment of heart failure patients poorly reflects the hemodynamic status during daily living conditions

T. Fux,  M. Mangiavacchi,  S. Ghio,  P. Fotuhi,  M. Stahlberg,  P.A. Grandjean,  C. Linde,  F. Braunschweig, 
  • Page: 100
  • First Published: 20 July 2007
Free Access

427 NT-pro BNP is valuable for monitoring of hemodynamics in heart transplant candidates

P. Lupinek,  I. Malek,  M. Kubanek,  V. Porizka,  J. Kautzner, 
  • Pages: 100-101
  • First Published: 20 July 2007
Free Access

428 Predominant role of insulin resistance in the development of heart failure induced by global ischaemia in conscious rabbits with aortic regurgitation

B. Peitl,  P. Kovacs,  B. Literati-Nagy,  R. Sari,  J. Nemeth,  G. Paragh,  Z. Szilvassy, 
  • Page: 101
  • First Published: 20 July 2007
Free Access

429 Metabolic syndrome impairs functional recovery in patients with chronic heat failure enrolled in a cardiac rehabilitation program

G. Caminiti,  G. Marazzi,  R. Massaro,  A. Tulli,  B. Sposato,  G. Rosano,  M. Volterrani, 
  • Page: 101
  • First Published: 20 July 2007
Free Access

430 Calpain involvement for the progression of heart failure (HF) via disruption of dystrophin (Dys)-associated proteins after myocardial infarction

H. Kumagai,  M. Takahashi,  M. Koshimizu,  H. Yoshida,  K. Tanonaka,  F. Masui,  S. Takeo,  T. Toyo-Oka, 
  • Pages: 101-102
  • First Published: 20 July 2007
Free Access

431 Non-revascularized human hibernating and chronically stunned myocardium can adapt to long-term chronic ischemia

H. Wiggers,  S.S. Nielsen,  P. Holdgaard,  M. Halbirk,  T.T. Nielsen,  H. Egeblad,  M. Rehling,  H.E. Botker, 
  • Page: 102
  • First Published: 20 July 2007
Free Access

432 Rosiglitazone improves cardiac efficiency and recovery of ventricular function following ischemia in hearts from type 2 diabetic mice

O.-J. How,  T.S. Larsen,  A.D. Hafstad,  A.M. Khalid,  E.S.P. Myhre,  D.L. Severson,  E. Aasum, 
  • Page: 102
  • First Published: 20 July 2007
Free Access

433 The PPARgamma agonist rosiglitazone exerts direct anti-apoptotic effects in hypoxia/reoxygenation

H. Kilter,  M. Werner,  C. Roggia,  M. Boehm, 
  • Pages: 102-103
  • First Published: 20 July 2007
Free Access

434 Maximal inspiratory pressure as a determinant of exercise capacity in patients with chronic heart failure

I. Laoutaris,  A. Dritsas,  M.D. Brown,  A. Manginas,  M. Kallistratos,  O. Ionescou,  P.A. Alivizatos,  D.V. Cokkinos, 
  • Page: 103
  • First Published: 20 July 2007
Free Access

435 Heart failure and sleep disorders breathing: 61 consecutive subjects

D.S. Corone,  C. Darne,  T. Farrokhi,  A. Hattab,  S. Hardy,  F. Bechraoui,  F. Viau, 
  • Page: 103
  • First Published: 20 July 2007
Free Access

436 Left atrial function and work after surgical ventricular restoration in the treatment of advanced heart failure due to post-infarction ventricular dilatation

P. Dardas,  N.E. Mezilis,  D.D. Tsikaderis,  V. Ninios,  H. Boudoulas,  A.A. Pitsis, 
  • Pages: 103-104
  • First Published: 20 July 2007
Free Access

437 Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnoea

N. Dursunoglu,  D. Dursunoglu,  S. Ozkurt,  S. Gur,  G. Ozalp,  F. Evyapan, 
  • Page: 104
  • First Published: 20 July 2007
Free Access

438 Distinct effects of chronic left ventricular pressure overload in normal and diabetic hearts

M. Vasconcelos,  I. Falcao-Pires,  N. Goncalves,  A. Leite-Moreira, 
  • Page: 104
  • First Published: 20 July 2007
Free Access

439 Tenascin-C expression as a marker for a Coxsackievirus B3 myocarditis

V. Ruppert,  T. Jonsdottir,  S. Pankuweit,  B. Maisch, 
  • Page: 104
  • First Published: 20 July 2007
Free Access

440 Impact of introducing natriuretic peptide assay for patients presenting acutely to secondary care with suspected heart failure

S. Mani,  A. Lokare,  A. Fuat,  J.I. Johnston,  W.S.A. Smellie,  J.J. Murphy, 
  • Page: 105
  • First Published: 20 July 2007
Free Access

441 Neurohumoral activity, heart failure and prognosis in patients with end stage renal disease treated by chronic haemodialysis

J. Spinar,  O. Ludka,  J. Vitovec,  L. Spinarova,  D. Sobotova,  L. Vitovcova,  L. Dusek, 
  • Page: 105
  • First Published: 20 July 2007
Free Access

442 Obese subjects with heart failure have lower urinary N-terminal pro-brain natriuretic peptide plasma levels irrespective of the etiology

M. Rivera Otero,  F. Marin,  R. Cortes,  L. Martinez Dolz,  J.L. Perez Bosca,  M.J. Sancho Tello,  V. Bertomeu,  M. Portoles, 
  • Pages: 105-106
  • First Published: 20 July 2007
Free Access

443 Relation of B-type natriuretic peptide to left ventricular wall stress in patients with dilated cardiomyopathy assessed by cardiac magnetic resonance imaging

P. Alter,  H. Rupp,  M.B. Rominger,  K.J. Klose,  B. Maisch, 
  • Page: 106
  • First Published: 20 July 2007
Free Access

444 Chronic renal insufficiency affects fractional renal extraction of Nt-proBNP but not BNP in patients with heart failure

W. Mullens,  J. Bartunek,  T. Boussy,  B. Van Vlem,  M. De Proft,  S. Verstreken,  M. Goethals,  M. Vanderheyden, 
  • Page: 106
  • First Published: 20 July 2007
Free Access

445 Variability of NT-ProBNP levels in patients with stable heart failure

J.P. Araujo,  A. Azevedo,  P. Lourenco,  A. Ferreira,  F. Rocha-Goncalves,  P. Bettencourt, 
  • Page: 106
  • First Published: 20 July 2007
Free Access

446 Utility of NT-proBNP for the diagnosis of heart failure in an heterogeneous population of patients with dyspnea. A Spanish mutlicentric study

M. Anguita,  J.C. Castillo,  P. Montes,  A. Martinez,  On behalf of NT-proBNP-IC Spanish Multicentric Study , 
  • Page: 107
  • First Published: 20 July 2007
Free Access

447 Predictors of left ventricular remodeling in patients after acute myocardial infarction treated with primary angioplasty

I. Swiatkiewicz,  A. Grubecki,  M. Kozinski,  A. Sukiennik,  J. Kubica, 
  • Page: 107
  • First Published: 20 July 2007
Free Access

448 Prognostic value of brain natriuretic peptide and an enhanced ventilatory response during cardiopulmonary exercise test in patients with heart failure

A.B. Scardovi,  R. De Maria,  C. Coletta,  S. Perna,  N. Aspromonte,  P. D'Errigo,  R. Ricci,  V. Ceci,  On behalf of T. Di Giacomo, S Rosato , 
  • Page: 107
  • First Published: 20 July 2007
Free Access

449 Serial measurements of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction

B.S. Yoo,  H.M. Choi,  H.Y. Ryu,  J.Y. Kim,  S.H. Lee,  J. Yoon,  K.H. Choe, 
  • Page: 108
  • First Published: 20 July 2007
Free Access

450 Correlation of body mass index and B type natriuretic peptide in patients presenting with shortness of breath

V. Jeevanantham,  R. Shrivastava,  A. Khan,  S. Nanapanneni,  M. Sengodan,  D. Hsi, 
  • Page: 108
  • First Published: 20 July 2007
Free Access

451 Elevated brain natriuretic peptide levels predict a failure of cardioversion in patients with atrial fibrillation

H. Takase,  T. Toriyama,  T. Okado,  S. Tanaka,  Y. Dohi, 
  • Page: 108
  • First Published: 20 July 2007
Free Access

452 Withdrawn Effects of atrasentan, an endothelin—A receptor antagonist, on cardiomyopathy and vascular dysfunction in diabetic mice with myocyte-specific overexpression of eNOS

G. Woelkart,  H. Stessel,  F. Brunner, 
  • Page: 109
  • First Published: 20 July 2007
Free Access

453 Contractile property alterations in failing human myocardium after treatments by amiodarone

D. Kondrat'eva,  S.A. Afanas'ev,  A.V. Evtushenko,  V.V. Evtushenko,  S. Popov,  T. Rebrova, 
  • Page: 109
  • First Published: 20 July 2007
Free Access

454 Inverse correlation between testosterone and cardiac function in heart failure patients with erectile dysfunction. Is there a resistance to testosterone?

E.A. Bocchi,  S.A. Ferreira,  V.O. Carvalho,  G.G. Guimaraes, 
  • Pages: 109-110
  • First Published: 20 July 2007
Free Access

455 The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced heart failure in conscious rabbits

Z. Szilvassy,  R. Sari,  J. Nemeth,  B. Peitl, 
  • Page: 110
  • First Published: 20 July 2007
Free Access

456 Acute cardiorespiratory modulation using cardiac pacemakers in heart failure

C. Manisty,  K. Willson,  J.E. Davies,  Z.I. Whinnett,  A. Hughes,  J. Mayet,  D.P. Francis, 
  • Page: 110
  • First Published: 20 July 2007
Free Access

522 Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction

D. Vanhoutte,  M. Schellings,  M.A. Stepp,  P. Carmeliet,  F. Van de Werf,  S. Heymans, 
  • Page: 111
  • First Published: 20 July 2007
Free Access

523 A stretch-specific gene expression pattern in cardiomyocytes

D. Frank,  C. Kuhn,  B. Brors,  H.A. Katus,  N. Frey, 
  • Pages: 111-112
  • First Published: 20 July 2007
Free Access

524 IL-4 suppresses intramyocardial inflammation and improves the imbalance in the matrix degradation system in murine chronic myocarditis

S. Rutschow,  C. Kampf,  A. Kallwellis-Opara,  D. Westermann,  S. Jaeger,  W. Rother,  C. Tschope,  M. Pauschinger, 
  • Page: 112
  • First Published: 20 July 2007
Free Access

525 A novel role for bone marrow stem cells in arteriogenesis in vivo

S. Zacchigna,  L. Zacchigna,  L. Pattarini,  A. Salvi,  G.F. Sinagra,  M. Giacca, 
  • Page: 112
  • First Published: 20 July 2007
Free Access

526 Role of aldosterone in development of secondary coronary endothelial dysfunction in transgenic mice model of heart failure

L. Drelicharz,  V.I. Kozlovski,  S. Chlopicki, 
  • Page: 112
  • First Published: 20 July 2007
Free Access

527 Cardiomyocyte-restricted overexpression of C-type natriuretic peptide improves cardiac remodeling after myocardial infarction in mice

Y. Wang,  M. de Waard,  H.-P. Schultheiss,  D.J. Duncker,  T. Walther, 
  • Page: 113
  • First Published: 20 July 2007
Free Access

528 Effects of recombinant human erythropoietin on left ventricular diastolic and systolic function, and plasma biomarkers of neurohormonal activation in patients with chronic heart failure and anaemia

K. Kourea,  J.T. Parissis,  D. Farmakis,  F. Panou,  G. Filippatos,  S. Adamopoulos,  D. Kremastinos, 
  • Page: 114
  • First Published: 20 July 2007
Free Access

529 Improving pharmacological treatment of heart failure (HF) through networking: drug prescription patterns in a national cardiologist network vs community

A. Di Lenarda,  G. Gigli,  G. Alunni,  G. Cacciatore,  L. Tarantini,  F. Oliva,  M. Gorini,  R. De Maria, 
  • Page: 114
  • First Published: 20 July 2007
Free Access

530 Chronic Renal Insufficiency is associated with an underuse of recommended heart failure therapies

M. Galinier,  P. Assyag,  P. De Groote,  A. Ducardonnet,  R. Isnard,  G. Jondeau,  I. Leurs,  M. Komajda, 
  • Page: 115
  • First Published: 20 July 2007
Free Access

531 Incidence and predictors of hyperkalemia in patients with heart failure - an analysis of the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) program

A.S. Desai,  J.J.V. McMurray,  C.B. Granger,  S. Yusuf,  J.W. Hainer,  B. Olofsson,  E.L. Michelson,  K. Swedberg,  On behalf of CHARM Investigators , 
  • Page: 115
  • First Published: 20 July 2007
Free Access

532 The drug dosages are not influenced by the number of recommended treatments prescribed in chronic heart failure: results of the French survey IMPACT-RECO

P. Assyag,  P. De Groote,  A. Ducardonnet,  R. Isnard,  M. Galinier,  G. Jondeau,  I. Leurs,  M. Komajda, 
  • Pages: 115-116
  • First Published: 20 July 2007
Free Access

533 Underuse of ACE inhibitors, beta-blockers and spironolactone in patients with heart failure is primarily due to lack of initiation of treatment

G.H. Gislason,  J.N. Rasmussen,  S.Z. Abildstrom,  T.K. Schramm,  P. Buch,  L. Kober,  M. Madsen,  C. Torp-Pedersen, 
  • Page: 116
  • First Published: 20 July 2007
Free Access

534 Aldosterone antagonists in chronic heart failure outpatients

G. Borelli,  S. Zingaro,  M. Coceani,  S. Guideri,  L. Rondinini,  R. Mariotti, 
  • Page: 116
  • First Published: 20 July 2007
Free Access

535 Effect of the optimal neurohormonal blockade on survival in high-risk patients groups with chronic heart failure

M.H. Starczewska,  M. Roik,  S. Stawicki,  G. Opolski, 
  • Page: 117
  • First Published: 20 July 2007
Free Access

536 The effect of diuretics on peak oxygen consumption and quality of life in patients with compensated left ventricular dysfunction

S. Gupta,  C. Waywell,  P. Clayton,  N. Gandhi,  T. Coppinger,  N.H. Brooks,  L. Neyses, 
  • Page: 117
  • First Published: 20 July 2007
Free Access

537 Effects of the Ca2+-sensitizer levosimendan continuous infusion on inflammatory process in patients with advanced congestive heart failure

A. Trikas,  G. Latsios,  C. Antoniades,  K. Vasiliadou,  D. Tousoulis,  C. Tentolouris,  J. Karamitros,  C. Stefanadis, 
  • Pages: 117-118
  • First Published: 20 July 2007
Free Access

538 The concomitant administration of levosimendan and dobutamine further improves both diastolic and systolic function as compared with the use of each drug alone: a radionuclide ventriculographic study

Y. Cavusoglu,  A. Citak,  E. Entok,  A. Birdane,  N. Ata,  B. Gorenek,  A. Unalir,  B. Timuralp, 
  • Page: 118
  • First Published: 20 July 2007
Free Access

539 Significant brain natriuretic peptide reduction predicts survival in end-stage heart failure patients treated with intermittent inotropic infusions

C. Batziou,  E. Tsagalou,  N. Lazaris,  S. Sarafoglou,  M. Bonios,  G. Alexopoulos,  J. Kanakakis,  J. Nanas, 
  • Page: 118
  • First Published: 20 July 2007
Free Access

540 Clinical outcomes of end-stage heart failure patients treated with a combination of chronic intermittent inotropic infusions and amiodarone

S. Drakos,  M. Bonios,  G. Alexopoulos,  E. Kaldara,  C. Pierrakos,  S. Sarafoglou,  J. Kanakakis,  J. Nanas, 
  • Page: 118
  • First Published: 20 July 2007
Free Access

541 Tolerability of CHARM-ADDED candesartan in “real-life” patients with advanced chronic heart failure

M.R. MacDonald,  N.M. Hawkins,  M. Shaw,  J.J.V. McMurray,  H.J. Dargie,  M.C. Petrie, 
  • Page: 119
  • First Published: 20 July 2007
Free Access

542 Effect of beta-blocker therapy to left ventricular systolic function and functional capacity in patients with mild to moderate heart failure: comparison metoprolol succinate with carvedilol

S. Arslan,  M.K. Erol,  E. Bozkurt,  F. Gundogdu,  H.Y. Gurlertop,  H. Senocak, 
  • Page: 119
  • First Published: 20 July 2007
Free Access

543 Effect of beta-blocker therapy to left atrial function in patients with mild to moderate heart failure: comparison metoprolol succinate with carvedilol

S. Arslan,  M.K. Erol,  E. Bozkurt,  M. Acikel,  F. Gundogdu,  S. Atesal,  H. Senocak, 
  • Pages: 119-120
  • First Published: 20 July 2007
Free Access

544 Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: a post-hoc analysis of the CHARM-Added trial

J.J.V. McMurray,  C.B. Granger,  E.L. Michelson,  B. Olofsson,  J. Ostergren,  S. Yusuf,  K. Swedberg,  M.A. Pfeffer,  on behalf of The CHARM Investigators , 
  • Page: 120
  • First Published: 20 July 2007
Free Access

545 Effect of long term therapy with beta-blocker carvedilol on renin-angiotensin-aldosterone system activity: comparative study with angiotensin-converting enzyme inhibitor enalapril in congestive heart

A. Skvortsov,  V. Mareev,  N. Podzarskaya,  G. Litonova,  N. Baklanova,  Y. Belenkov, 
  • Page: 120
  • First Published: 20 July 2007
Free Access

546 Long-term bisoprolol therapy effectively controls RAAS activity and improves heart rate variability in severe congestive heart failure patients

A. Skvortsov,  S. Nasonova,  A. Sychov,  Y.A. Orlova,  G. Litonova,  N. Baklanova,  V. Mareev,  Y. Belenkov, 
  • Pages: 120-121
  • First Published: 20 July 2007
Free Access

547 Long-term combined therapy of ACE inhibitor quinapril and ARB valsartan have not additional beneficial effect on HRV parameters compared to monotherapy with either quinapril or valsartan in CHF

A. Skvortsov,  S. Nasonov,  G. Arbolishvili,  A. Sychev,  N. Baklanova,  V. Mareev,  Y. Belenkov, 
  • Page: 121
  • First Published: 20 July 2007
Free Access

548 The effect of darbepoetin alfa treatment on clinical outcomes in anemic patients with symptomatic heart failure: a preplanned pooled analysis of two randomized, double-blind, placebo-controlled trials

W.T. Abraham,  M. Klapholz,  I. Anand,  B. Knusel,  D. Rosser,  N. Baker,  Y. Sun,  D.J. van Veldhuisen,  on behalf of The Anemia Correction in Heart Failure Study Group and Amgen Inc. , 
  • Page: 121
  • First Published: 20 July 2007
Free Access

549 Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HeFT

J.K. Ghali,  I. Anand,  W.T. Abraham,  G.C. Fonarow,  B. Greenberg,  H. Krum,  B.M. Massie,  P. Armstrong,  On behalf of The STAMINA-HeFT Study Group and Amgen Inc. , 
  • Page: 122
  • First Published: 20 July 2007
Free Access

550 Influence on NT-proBNP levels and hospitalization of correction of mild anemia with intravenous iron and erythropoietin in patients with severe chronic heart failure

J. Comin-Colet,  V. Ruiz-Ruiz,  A. Ortega,  J. Morales,  R. Malo,  B. Garcia-Bascunana,  L. Coca,  J. Bruguera-Cortada, 
  • Page: 122
  • First Published: 20 July 2007
Free Access

551 Bromocriptine prevents deterioration of cardiac function in patients with PPCM after subsequent pregnancy

O. Forster,  D. Hilfiker-Kleiner,  A. Yip,  A. Becker,  M. Nel,  K. Sliwa-Hahnle, 
  • Pages: 122-123
  • First Published: 20 July 2007
Free Access

552 The safety and efficacy of repeated doses of Levosimendan in patients with advanced heart failure

N.M. Parle,  L. Dembo,  M. Erickson,  G. O'Driscoll, 
  • Page: 123
  • First Published: 20 July 2007
Free Access

553 Reduction of circulating levels of brain natriuretic peptide and C-reactive protein in patients with congestive heart failure after intermittent administration of levosimendan for 3 months

I. Vassiliadis,  S. Thomopoulou,  S. Mavrogeni,  E. Papadopoulou,  G. Giamouzis,  D.V. Cokkinos, 
  • Page: 123
  • First Published: 20 July 2007
Free Access

554 Factors limiting betablockers prescription by cardiologists in systolic heart failure in France

G. Jondeau,  P. Assyag,  P. De Groote,  A. Ducardonnet,  M. Galinier,  R. Isnard,  I. Leurs,  M. Komajda, 
  • Pages: 123-124
  • First Published: 20 July 2007
Free Access

555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM-Added trial

R.A.P. Weir,  J.J.V. McMurray,  C.B. Granger,  B. Olofsson,  J. Ostergren,  S. Yusuf,  K. Swedberg,  M.A. Pfeffer,  On behalf of The CHARM Investigators , 
  • Page: 124
  • First Published: 20 July 2007
Free Access

556 Estimation of antioxidative effect of carvedilol in patients with ischaemic heart failure

J. Kowalski,  L. Pawlicki,  R. Irzmanski,  M. Barylski,  M. Banach, 
  • Page: 124
  • First Published: 20 July 2007
Free Access

557 Acute heart failure complicating ST-elevation acute myocardial infarction: levosimendan does not offer any long term survival benefit over dobutamine treatment

M.J. Garcia Gonzalez,  A. Dominguez Rodriguez,  S. Samimi-Fard,  J.J. Ferrer Hita,  C. Rubio-Iglesias Garcia,  A. Sanchez-Grande Flecha,  P. Abreu Gonzalez, 
  • Pages: 124-125
  • First Published: 20 July 2007
Free Access

558 Efficiency of nebivolol, carvedilol, metoprolol administration in complex therapy of patients with chronic heart failure

A.G. Evdokimova,  A.E. Radzevich,  O.I. Tereshenko,  E.V. Kovalenko, 
  • Page: 125
  • First Published: 20 July 2007
Free Access

559 Short term simvastatin use in patients with heart failure of ischemic origin. Changes of blood lipids, markers of inflammation and left ventricular function

I.N. Smetanina,  N.A. Vaulin,  N.A. Gratsiansky, 
  • Page: 125
  • First Published: 20 July 2007
Free Access

560 ACE inhibitors are more effective in chronic heart failure patients with metabolic syndrome

M. Fukunami,  S. Tamaki,  T. Yamada,  T. Mine,  T. Morita,  Y. Tsukamoto,  M. Masuda,  K. Okuda, 
  • Pages: 125-126
  • First Published: 20 July 2007
Free Access

561 Pharmacokinetic-pharmacodynamic modeling and simulation of darbepoetin alfa once-monthly dosing regimen for the design of clinical trials in anemic patients with chronic heart failure

B. Agoram,  M. Toupikov, 
  • Page: 126
  • First Published: 20 July 2007
Free Access

562 The clinical improvement of end-stage heart failure is not accompanied by correction of anemia

S. Drakos,  E. Kaldara,  M. Bonios,  D. Karageorgopoulos,  C. Pierrakos,  K. Liarelli,  T. Zafeiriou,  M. Anastasiou-Nana, 
  • Page: 126
  • First Published: 20 July 2007
Free Access

563 Long-term acceptance of nebivolol in idiopathic dilated cardiomyopathy patients

T.A. Abdullaev,  N.A. Kurbanov,  I.R. Bekbulatova,  G.A. Nagaeva, 
  • Page: 126
  • First Published: 20 July 2007
Free Access

564 Recommended b-blockers for treatment of congestive heart failure with chronic obstructive pulmonary disease

P.F. Fedotov,  I. Nesterova,  M. Sitnikova,  E. Shlyachto, 
  • Page: 127
  • First Published: 20 July 2007
Free Access

565 The tissue effects of long-term treatment with ACE inhibitor and metoprolol in elderly patients with congestive heart failure (CHF) and preserved systolic function

O.V. Soya,  O.V. Kuryata, 
  • Page: 127
  • First Published: 20 July 2007
Free Access

566 The effects of intermittent and long time glucose-insulin-potassium infusion on systolic functions

N. Kalay,  I. Ozdogru,  N.K. Eryol,  Y. Cetinkaya,  A. Dogan,  I. Gul,  T. Inanc,  A. Oguzhan, 
  • Page: 127
  • First Published: 20 July 2007
Free Access

567 Influence of pentoxifilline in addition to conventional heart failure treatment on clinical status profile and immunne systems in patients with chronic heart failure

A. Sychov,  E. Nasonov,  V. Mareev,  A. Scvorcov,  S. Nasonova,  E. Alexandrova,  V. Masenko,  Y. Belenkov, 
  • Pages: 127-128
  • First Published: 20 July 2007
Free Access

568 The economic burden of heart failure in Italy, 2004

S. Lottaroli,  C. Politi,  S. Birri,  R.G. Panarace,  L. Cavalieri d'Oro,  P. Zuech,  R. De Maria,  V. Mapelli, 
  • Page: 128
  • First Published: 20 July 2007
Free Access

569 The burden of heart failure in Italy: an analysis of regional administrative databases

R.G. Panarace,  A. Deales,  A. Zucchi,  C. Cerra,  L. Milani,  P. Zuech,  R. De Maria,  A. Di Lenarda,  On behalf of Working Group on Heart Failure Italian Hospital Cardiologists Ass. , 
  • Page: 128
  • First Published: 20 July 2007
Free Access

570 Age-related trend in hospital readmissions for heart failure: an analysis from regional administrative databases

G. Pulignano,  A. Di Lenarda,  F. Oliva,  G. Gigli,  S. Lottaroli,  P. Di Gaetano,  D. Gregori,  R. De Maria, 
  • Pages: 128-129
  • First Published: 20 July 2007
Free Access

571 Weight loss and quality of life in heart failure

F. Castrogiovanni,  R. Bini,  L. Rondinini,  M. Coceani,  G. Borelli,  S. Zingaro,  R. Mariotti, 
  • Page: 129
  • First Published: 20 July 2007
Free Access

572 Pattern of cardiac insufficiency illness perception and self-efficacy in coronary heart disease patients treated by drug eluting stents

G. Trovato,  D. Catalanp,  D. Spadaro,  G. Martines,  M. Interrigi,  G. Garufi,  A. Tonzuso,  C. Tamburino, 
  • Page: 129
  • First Published: 20 July 2007
Free Access

573 Resynchronisation therapy and reduce costing save in patients with heart failure

P.M.G. Agricola,  M. Cacucci,  A. Catanoso,  M. Nanetti,  O. Durin,  G. Donato,  G. Inama, 
  • Pages: 129-130
  • First Published: 20 July 2007
Free Access

574 Are sociodemographic factors associated with patient knowledge and self management measures in heart failure patients?

M. Lainscak,  D. Stevancec,  A. Rezonja,  A. Dumic,  A. Rezonja, 
  • Page: 130
  • First Published: 20 July 2007
Free Access

575 Failure of an educational program for heart failure: experiences of the Vienna heart school

S. Folkmann,  M. Avanzini,  T. Quinton,  C. Stoellberger, 
  • Page: 130
  • First Published: 20 July 2007
Free Access

576 Noncompliance factors in Russian chronic heart failure patients

V. Pyankov,  Y. Chuyasova, 
  • Pages: 130-131
  • First Published: 20 July 2007
Free Access

577 Efficiency of interactive training in patients with II–IV FC CHF

A. Rylova,  G. Arutyunov,  A. Evzerikhina, 
  • Page: 131
  • First Published: 20 July 2007
Free Access

578 Effect of statin therapy in different groups of patients with chronic heart failure - 1 year observation

M. Roik,  M.H. Starczewska,  S. Stawicki,  J. Kochanowski,  Z. Huczek,  G. Opolski, 
  • Page: 131
  • First Published: 20 July 2007
Free Access

579 Feasibility, safety and ability of cardiopulmonary exercise test in elderly patients with chronic heart failure

A.B. Scardovi,  C. Coletta,  N. Aspromonte,  S. Perna,  R. De Maria,  B. Krakowska,  R. Ricci,  V. Ceci,  on behalf of T. Di Giacomo, M Greggi , 
  • Pages: 131-132
  • First Published: 20 July 2007
Free Access

580 Anaemia in men with chronic heart failure: an element of multiple anabolic depletion

E.A. Jankowska,  A. Grzeslo,  B. Biel,  T. Witkowski,  J. Petruk-Kowalczyk,  J. Majda,  W. Banasiak,  P. Ponikowski, 
  • Page: 132
  • First Published: 20 July 2007
Free Access

581 Iron deficiency is a common finding in patients with stable chronic heart failure

A. Grzeslo,  E.A. Jankowska,  T. Witkowski,  J. Majda,  J. Petruk-Kowalczyk,  W. Banasiak,  P. Ponikowski, 
  • Page: 132
  • First Published: 20 July 2007
Free Access

582 Bone status and bone loss over time in men with chronic heart failure, and their clinical and hormonal determinants

E.A. Jankowska,  A. Cwynar,  J. Jakubaszko,  J. Majda,  J. Petruk-Kowalczyk,  K. Wegrzynowska,  W. Banasiak,  P. Ponikowski, 
  • Pages: 132-133
  • First Published: 20 July 2007
Free Access

583 Correlation between cholesterol levels and nutritional status in heart failure

J.P. Araujo,  A. Azevedo,  P. Lourenco,  A. Ferreira,  F. Rocha-Goncalves,  P. Bettencourt, 
  • Page: 133
  • First Published: 20 July 2007
Free Access

584 Renal pulsatility index predicts the progression of renal dysfunction in patients with chronic heart failure

L. Conte,  A. Rossi,  M.A. Cicoira,  A. Pacchioni,  A. Anselmi,  G. Golia,  P. Zardini,  C. Vassanelli, 
  • Page: 133
  • First Published: 20 July 2007
Free Access

585 The correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure

M. Feola,  M. Peano,  G.L. Rosso,  M. Agostini,  N. Aspromonte,  G. Carena,  L. Salvatico,  E. Uslenghi, 
  • Page: 133
  • First Published: 20 July 2007
Free Access

586 Endurance training potentiates exercise capacity in patients with chronic heart failure referred for cardiac resynchronization therapy

V. Conraads,  M. Vanderheyden,  I. Blankoff,  H. Miljoen,  S. Verstreken,  J. De Sutter,  P. Beckers, 
  • Page: 134
  • First Published: 20 July 2007
Free Access

587 Higher prevalence and severity of sleep disordered breathing in patients with symptomatic ischemic compared to non-ischemic heart failure

B. Lamp,  D. Horstkotte,  O. Oldenburg, 
  • Page: 134
  • First Published: 20 July 2007
Free Access

588 The prognostic role of anemia in acute heart failure. Data from the Italian survey on acute heart failure

L. Scelsi,  L. Tavazzi,  A.P. Maggioni,  D. Lucci,  G. Cacciatore,  G. Ansalone,  F. Oliva,  M. Porcu,  On behalf of Italian Survey on Acute Heart Failure , 
  • Page: 134
  • First Published: 20 July 2007
Free Access

589 End-tidal carbon dioxide pressure during maximum cardiopulmonary exercise testing predicts mortality in patients with congestive heart failure

V. Georgiopoulou,  D. Sakellariou,  J. Venetsanakos,  S. Dimopoulos,  S. Drakos,  G. Maroulidis,  M. Anastasiou-Nana,  S. Nanas, 
  • Page: 135
  • First Published: 20 July 2007
Free Access

590 Right ventricular dysfunction and pulmonary hypertension are independent prognostic predictors of survival in left ventricular dysfunction regardless of ischemic etiology

L. La Vecchia,  L. Varotto,  G.L. Spadaro,  C. Bonanno,  P. Vincenzi,  E. Cabianca,  L. Zanolla,  A. Fontanelli, 
  • Page: 135
  • First Published: 20 July 2007
Free Access

591 Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients

C.J. Petrie,  A.A. Voors,  D.J. van Veldhuisen, 
  • Page: 135
  • First Published: 20 July 2007
Free Access

592 BNP and cardiac troponin T combination predicts cardiac events in patients hospitalized for acute heart failure

N. Aspromonte,  M. Feola,  A.B. Scardovi,  A. D'Eri,  F. Noventa,  P. Giovinazzo,  L. Milani,  R. Valle, 
  • Pages: 135-136
  • First Published: 20 July 2007
Free Access

593 Two-year prognosis in chronic heart failure patients undergone therapeutic education and out-patient observation

S.S. Yakushin,  N.N. Nikulina, 
  • Page: 136
  • First Published: 20 July 2007
Free Access

594 Correlation of atrial fibrillation with mortality in patients with heart failure: is influenced by the etiology of heart failure?

E. Zamora,  J. Lupon Roses,  A. Urrutia,  B. Gonzalez,  S. Altimir,  R. Coll,  C. Diez,  V. Valle, 
  • Page: 136
  • First Published: 20 July 2007
Free Access

595 Prognostic significance of late potentials in myocardial infarcted patients with heart failure

M.V. Ivan,  M.P. Turcan, 
  • Pages: 136-137
  • First Published: 20 July 2007
Free Access

596 Prognostic sensitivity of different time points of the ve/vco2 slope in patients with suspected heart failure

L. Ingle,  K. Goode,  S. Carroll,  J.G.F. Cleland,  A.L. Clark, 
  • Page: 137
  • First Published: 20 July 2007
Free Access

597 Prognostic value of end-systolic wall stress over ejection fraction ratio in heart failure patients

E. Rosello,  M. Rivera Otero,  J.L. Perez Bosca,  R. Cortes,  F. Marin,  A. Salvador,  A. Jordan,  V. Miro, 
  • Page: 137
  • First Published: 20 July 2007
Free Access

598 Big endothelin-1 plasma levels have independent prognostic value in heart failure patients

M. Rivera Otero,  V. Miro,  F. Garcia de Burgos,  R. Valero,  E. Rosello,  V. Climent,  R. Paya,  V. Mora, 
  • Pages: 137-138
  • First Published: 20 July 2007
Free Access

599 Mitral regurgitation as predictor of mortality in patients with acute coronary syndromes

A. Persson,  M. Hartford,  J. Herlitz,  T. Karlsson,  T. Omland,  K. Caidahl, 
  • Page: 138
  • First Published: 20 July 2007
Free Access

600 Hyponatremia, kidney disease and outcome in patients with chronic heart failure

M. Gotzmann,  J. Stypmann,  J. Sindermann,  R. Gradaus,  C. Bruch, 
  • Page: 138
  • First Published: 20 July 2007
Free Access

601 Inpatient and outpatient ultrafiltration with a portable device in a cardiology department: preliminary experience

A. Patrignani,  G. Forni,  A. Gualco,  F. Galli,  C. Opasich,  F. Cobelli, 
  • Pages: 138-139
  • First Published: 20 July 2007
Free Access

602 Comparison of the prognostic value of peak VO2, peak circulatory power and VE/VCO2 slope in chronic heart failure patients treated with beta-blockers

A. Silva Ferreira,  M. Mendes,  A. Ventosa,  C. Aguiar,  J. Ferreira,  A. Silva, 
  • Page: 139
  • First Published: 20 July 2007
Free Access

603 Temporal trends in survival and hospital admissions in patients with heart failure and preserved left ventricular function

M. Senni,  R. De Maria,  G. Cacciatore,  M. Parolini,  M. Porcu,  L. Tarantini,  A. Gavazzi, 
  • Page: 139
  • First Published: 20 July 2007
Free Access

604 Creatinine clearance calculated by Cockroft's formula is a highly predictive prognostic factor for two years mortality in a general heart failure population

E. Zamora,  J. Lupon Roses,  A. Urrutia,  A. Wilke,  B. Gonzalez,  C. Diez,  S. Altimir,  V. Valle, 
  • Pages: 139-140
  • First Published: 20 July 2007
Free Access

605 Nitrate use is associated with higher mortality in ambulatory patients with chronic heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF)

S. Baldasseroni,  A. Franchi,  L. Gonzini,  G. Lureti,  C. Marcon,  G. Perini,  G. Pes,  A.P. Maggioni,  On behalf of IN-CHF Investigators , 
  • Page: 140
  • First Published: 20 July 2007
Free Access

606 Usefulness of heart rate turbulence for prediction of cardiac death in dilated cardiomyopathy

G. Kozdag,  A. Agacdiken,  G. Kahraman,  T. Sahin,  U. Bildirici,  T. Kilic,  D. Ural,  B. Komsuoglu, 
  • Page: 140
  • First Published: 20 July 2007
Free Access

607 Renal dysfunction, as measured by the Modification of Diet in Renal Disease (MDRD) equations, and outcome in patients with advanced heart failure

R.S. Gardner,  K.S. Chong,  E. O'Meara,  A. Jardine,  T.A. McDonagh, 
  • Pages: 140-141
  • First Published: 20 July 2007
Free Access

608 Do we predict the risk of acute coronary syndromes in patients post myocardial infarction with heart failure or asymptomatic left ventricle dysfunction - 30-month follow-up of 320 patients

M. Kuch,  M. Janiszewski,  A. Mamcarz,  M. Chmielewski,  W. Braksator,  J. Kuch,  M. Dluzniewski, 
  • Page: 141
  • First Published: 20 July 2007
Free Access

609 Abnormal ECG is a significant prognostic marker in subjects with preserved left ventricular function including those with dyspnea - Five years of follow up in a middle-aged and elderly population

I.E. Raymond,  F. Pedersen,  J. Dimsits,  P.R. Hildebrandt, 
  • Pages: 141-142
  • First Published: 20 July 2007
Free Access

610 Frailty is an independent prognostic variable in very elderly patients with heart failure

G. Pulignano,  D. Del Sindaco,  A. Di Lenarda,  G. Cioffi,  L. Tarantini,  F. Leggio,  G.F. Sinagra,  E. Giovannini, 
  • Page: 142
  • First Published: 20 July 2007
Free Access

611 Heart failure predictors on admission in acute coronary syndromes

R. Couto,  J. Ferreira,  L. Raposo,  C. Aguiar,  A.M. Ferreira,  P. Goncalves,  S. Lima,  J. Aniceto Silva, 
  • Page: 142
  • First Published: 20 July 2007
Free Access

612 Is TIMI risk score as useful prognostic factor as BNP in STEMI

G. Krljanac,  A. Vojvodic,  M. Asanin,  S. Stankovic,  B. Stojanovic,  M. Banovic,  Z. Vasiljevic, 
  • Page: 142
  • First Published: 20 July 2007
Free Access

613 Myocardial jeopardy score as a new predictor of acute coronary events in patients with natural progression of coronary artery disease

I. Nedeljkovic,  M. Ostojic,  B. Beleslin,  A. Djordjevic-Dikic,  J. Stepanovic,  M. Nedeljkovic,  S. Stojkovic,  V. Giga, 
  • Page: 143
  • First Published: 20 July 2007
Free Access

614 Prognostic variables at first diagnosis can effectively predict long-term outcome in patients with idiopathic dilated cardiomyopathy

N. Ajmone Marsan,  C. Campana,  C. Martina,  L. Monti,  S. Ghio,  M. Pasotti,  E. Arbustini,  L. Tavazzi, 
  • Page: 143
  • First Published: 20 July 2007
Free Access

615 Long-term prognostic value of haemoglobin levels in hospitalized patients with acute heart failure

B. Redondo,  D.A. Pascual Figal,  J.A. Hurtado,  P. Penafiel,  P.L. Tornel,  D. Saura,  S. Moreno,  M. Valdes, 
  • Page: 143
  • First Published: 20 July 2007
Free Access

616 Short term prognosis in high risk patients with chronic cardiac failure: added benefit of primary ICD therapy?

L. Frankenstein,  M. Nelles,  D. Schellberg,  J. Graham,  H.A. Katus,  A. Remppis,  C. Zugck, 
  • Pages: 143-144
  • First Published: 20 July 2007
Free Access

617 Depressed low frequency-to-high frequency ratio of heart rate variability identifies patients with heart failure and systolic dysfunction at increased risk for sudden death

G. Arbolishvili,  Y. Orlova,  V. Mareev,  Y. Belenkov, 
  • Page: 144
  • First Published: 20 July 2007
Free Access

618 The prognostic value of heart rate response in patients with mild and moderate heart failure

G.-A. Dan,  A. Dan,  A. Buzea,  I. Daha,  C. Adam, 
  • Page: 144
  • First Published: 20 July 2007
Free Access

619 Low-dose dobutamine echocardiography in patients with dilated cardiomyopathy

A. Galrinho,  L. Moura Branco,  A. Timoteo,  J. Abreu,  R.M. Soares,  A. Santana,  J. Quininha, 
  • Page: 144
  • First Published: 20 July 2007
Free Access

620 Cystatin-C and the cardio-renal index predict outcome in patients with chronic heart failure

A. Vazir,  A. Bolger,  C. Loong,  T. Agustsson,  H. Penston,  R. Fink,  R. Kaprielian,  C. Chapman, 
  • Page: 145
  • First Published: 20 July 2007
Free Access

621 Prognostic value of anemia and additional role of NT-proBNP in patients with heart failure

G. Di Tano,  F. Scimone,  S. Micciulla,  M.G. Briguglio,  S. Masson,  R. Latini, 
  • Page: 145
  • First Published: 20 July 2007
Free Access

622 Blood urea nitrogen - an important prognostic marker in patients with chronic heart failure

M. Roik,  M.H. Starczewska,  S. Stawicki,  Z. Huczek,  J. Kochanowski,  G. Opolski, 
  • Pages: 145-146
  • First Published: 20 July 2007
Free Access

623 Recovery pattern and term of reversal of left ventricular remodeling in patients with congestive heart failure

K.H. Ryu,  M.C. Cho,  D.J. Choi,  E.-S. Jeon,  J.J. Kim,  S.C. Chae,  S.W. Han, 
  • Page: 146
  • First Published: 20 July 2007
Free Access

624 Improved ventilatory performance at submaximal effort following exercise training in severe CHF patients is independent of improvement in maximal aerobic capacity

R. Reuveni,  A. Pinchas,  Z. Iakobishvili,  R. Stein,  A. Battler,  T. Ben Gal, 
  • Page: 146
  • First Published: 20 July 2007
Free Access

625 Familial dilated cardiomyopathy: a long term follow-up study

E. Martins,  J. Silva-Cardoso,  M. Campelo,  S. Amorim,  B. Moura,  R. Rocha Goncalves, 
  • Pages: 146-147
  • First Published: 20 July 2007
Free Access

626 Day-time Cheyne-Stokes respiration and plasma B-type natriuretic peptide elevation in heart failure patients: incremental prognostic value

R. Poletti,  C. Passino,  L. Zyw,  C. Prontera,  F. Bramanti,  M. Emdin,  A. Giannoni, 
  • Page: 147
  • First Published: 20 July 2007
Free Access

627 Prognostic significance of heart rate variability in patients with heart failure and systolic dysfunction

G. Arbolishvili,  Y. Orlova,  V. Mareev,  Y. Belenkov, 
  • Page: 147
  • First Published: 20 July 2007
Free Access

628 Prognostic value of CA 125 in patients with advanced heart failure

S. Monteiro,  F. Franco,  P.F. Monteiro,  S. Costa,  H. Vieira,  L. Oliveira,  L. Coelho,  L.A. Providencia, 
  • Page: 147
  • First Published: 20 July 2007
Free Access

629 N-terminal pro brain natriuretic peptide and tumor necrosis factor alpha and outcome in patients with heart failure with reduced vs. preserved systolic function

N. Stancheva,  S. Tisheva,  S. Kurkchiev,  A. Goudev, 
  • Pages: 147-148
  • First Published: 20 July 2007
Free Access

630 Diabetes mellitus or symptoms of advenced heart failure - which is a stronger predictor of adverse outcome in patients after myocardial infarction?

M. Kuch,  M. Janiszewski,  A. Mamcarz,  K. Sadkowska,  W. Braksator,  M. Janiszewski,  J. Kuch,  M. Dluzniewski, 
  • Page: 148
  • First Published: 20 July 2007
Free Access

640 Glucose metabolism in patients with advanced heart failure

P.F. Monteiro,  J.G. Jones,  F. Franco,  C. Barosa,  S. Costa,  S. Monteiro,  L.M. Goncalves,  L.A. Providencia, 
  • Page: 149
  • First Published: 20 July 2007
Free Access

641 Fabry disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipids compartmentalization

M. Pieroni,  C. Chimenti,  F. De Cobelli,  E. Morgante,  A. Del Maschio,  C. Gaudio,  M.A. Russo,  A. Frustaci, 
  • Pages: 149-150
  • First Published: 20 July 2007
Free Access

642 Mid-regional pro-atrial natriuretic peptide (MR-proANP) better than N-terminal Pro B-type natriuretic peptide (NT-proBNP) predicts survival in patients with chronic heart failure (CHF)

S. Von Haehling,  E.A. Jankowska,  N. Morgenthaler,  P. Rozentryt,  W. Doehner,  P. Ponikowski,  A. Bergmann,  S.D. Anker, 
  • Page: 150
  • First Published: 20 July 2007
Free Access

643 Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP

J.P.E. Lassus,  V.-P. Harjola,  K. Siirila-Waris,  R. Sund,  J. Melin,  K. Pulkki,  K. Peuhkurinen,  M.S. Nieminen,  on behalf of FINN-AKVA study group , 
  • Page: 150
  • First Published: 20 July 2007
Free Access

644 Depletion in more than one endocrine anabolic axis identifies men with chronic heart failure of particularly high long-term mortality

E.A. Jankowska,  B. Biel,  J. Majda,  J. Petruk-Kowalczyk,  S.D. Anker,  W. Banasiak,  P.A. Poole-Wilson,  P. Ponikowski, 
  • Pages: 150-151
  • First Published: 20 July 2007
Free Access

645 Increased chemoceptive sensitivity to carbon dioxide during Cheyne-Stokes respiration in chronic heart failure is associated with adrenergic and cardiac natriuretic hormone

A. Giannoni,  M. Emdin,  R. Poletti,  C. Prontera,  M. Micalizzi,  C. Passino, 
  • Page: 151
  • First Published: 20 July 2007
Free Access

679 Use of spironolactone and incidence of severe hyperkalemia in patients enrolled in a heart failure programme

C. Belziti,  N. Vensentini,  N. Vulcano,  S. Fernandez, 
  • Page: 152
  • First Published: 20 July 2007
Free Access

680 The influence of primary care physicians education on their approach to heart failure diagnosis and treatment in the district of Poznan, Poland

M. Wierzchowiecki,  K. Poprawski,  A. Nowicka,  M. Kandziora,  A. Piatkowska,  K. Szymanowska,  R. Dankowski,  M. Pempera, 
  • Page: 152
  • First Published: 20 July 2007
Free Access

681 Withdrawn Long term cardiac rehabilitation outcome measures of a trial cohort of elderly patients with congestive heart failure

J. Austin,  R. Williams,  S. Hutchison,  L. Ross, 
  • Page: 153
  • First Published: 20 July 2007
Free Access

682 An audit of the first year of supplementary prescribing within a multi-disciplinary specialist heart failure service in the United Kingdom

H. Williams,  J. De Courcey,  J. Byrne,  M. Kearney, 
  • Page: 153
  • First Published: 20 July 2007
Free Access

683 A first picture of heart failure management programmes in Europe

T. Jaarsma,  A. Stromberg,  on behalf of Undertaking Nursing Interventions Throughout Europe (UNITE) group , 
  • Pages: 153-154
  • First Published: 20 July 2007
Free Access

684 A multidisciplinary heart failure care program based on a nurse-monitored outpatient clinic reduces readmissions, improves clinical status and quality of life after 6 months

G. Gaschino,  A. Chinaglia,  R. Asteggiano,  G. Titta,  D. Blanc,  D. Polito,  P. Lorusso,  R. Trinchero, 
  • Page: 154
  • First Published: 20 July 2007
Free Access

689 Copeptin, a stable fragment of the Vasopressin precursor, as a novel predictor of outcome in congestive heart failure, independent of BNP

M. Huelsmann,  R. Berger,  D. Moertl,  J. Struck,  N. Morgenthaler,  A. Bergmann,  R. Pacher, 
  • Page: 155
  • First Published: 20 July 2007
Free Access

690 Multimarker approach to risk stratification in chronic congestive heart failure

W.H. Yin,  J.W. Chen,  S.J. Lin,  M.S. Young, 
  • Page: 155
  • First Published: 20 July 2007
Free Access

691 Heart failure pharmacotherapy according to current guidelines improves prognosis also in old and female patients

S. Stork,  H.W. Hense,  E. Ertl,  C.E. Angermann, 
  • Pages: 155-156
  • First Published: 20 July 2007
Free Access

692 A novel prognostic index including comorbidities for stable heart failure validated in different clinical settings

M. Senni,  G. Santilli,  P. Parrella,  R. De Maria,  G. Alari,  M. Scuri,  P. Ferrazzi,  A. Gavazzi, 
  • Page: 156
  • First Published: 20 July 2007
Free Access

693 The combination of neurohormonal, ventilatory and echocardiographic evaluation improves risk stratification in patients with chronic heart failure

A.B. Scardovi,  R. De Maria,  C. Coletta,  N. Aspromonte,  S. Perna,  P. D'Errigo,  R. Ricci,  V. Ceci, 
  • Page: 156
  • First Published: 20 July 2007
Free Access

694 Diabetes reduces the likelihood of more favorable outcomes in women than men with heart failure: Retrospective analysis of the DIG trial

F.M. Alla,  A.Y. Al-Hindi,  C.R. Lee,  T.A. Schwartz,  J.H. Patterson,  J.K. Ghali,  K.F. Adams Jr, 
  • Page: 157
  • First Published: 20 July 2007
Free Access

695 Heart failure mortality in Venezuela during the years 2000-2004

E. Silva,  J.J. Villasmil,  M.A. Luzardo,  G. Bermudez,  C. Esis,  S. Briceno, 
  • Page: 158
  • First Published: 20 July 2007
Free Access

696 Hospital at home: descriptive study of patients with chronic heart failure (CrHF) attended at home

J. Guillamont,  A. Sole,  S. Gonzalez,  A. Perez Iturriaga,  C. Davila,  P. Biada,  M. Sopena,  J. Escarrabill, 
  • Pages: 158-159
  • First Published: 20 July 2007
Free Access

697 Heart failure patient improvements in clinical status, hospitalisation and costing by multidisciplinary team management programme

M.F. Piepoli,  G. Villani,  D. Aschieri,  M.S. Pisati,  E. Iconomou,  S. Arruzzoli,  A. Capucci, 
  • Page: 159
  • First Published: 20 July 2007
Free Access

698 Lifestyle advice in hospitalized heart failure patients: experience from the EuroHeart Failure survey

M. Lainscak,  I. Keber,  M.J. Lenzen,  F. Follath,  K. Swedberg,  M. Komajda,  J.G.F. Cleland, 
  • Page: 159
  • First Published: 20 July 2007
Free Access

699 Is NYHA functional class perceived similarly among nurses, doctors and patients?

B. Gonzalez,  J. Lupon Roses,  A. Urrutia,  A. Wilke,  C. Diez,  S. Altimir,  R. Coll,  V. Valle, 
  • Pages: 159-160
  • First Published: 20 July 2007
Free Access

700 Influence of perceived psychosocial support on self care behaviour of patients with chronic heart failure managed in nurse-led heart failure clinics

A. Ortega-Gutierrez,  J. Comin-Colet,  S. Quinones,  J. Morales,  V. Ruiz,  B. Garcia-Bascunana,  N. Badosa,  J. Bruguera-Cortada, 
  • Page: 160
  • First Published: 20 July 2007
Free Access

701 Gender differences in elderly hospitalized heart failure patients with depressive symptoms

I. Lesman-Leegte,  T. Jaarsma,  R. Sanderman,  D.J. van Veldhuisen, 
  • Page: 160
  • First Published: 20 July 2007
Free Access

702 Perceived health status and thoughts about death in elderly patients with heart failure

A. Stromberg,  T. Jaarsma, 
  • Pages: 160-161
  • First Published: 20 July 2007
Free Access

703 Sexual problems in heart failure patients: is there a difference between Dutch and Swedish patients?

T. Jaarsma,  A. Stromberg, 
  • Page: 161
  • First Published: 20 July 2007
Free Access

704 Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats

M. Louhelainen,  E. Vahtola,  P. Kaheinen,  S. Merasto,  V. Kyto,  P. Finckenberg,  J. Levijoki,  E.M.A. Mervaala, 
  • Page: 161
  • First Published: 20 July 2007
Free Access

705 Cardiotoxicity of the chemotherapeutic agent, imatinib mesylate

R. Kerkela,  L. Grazette,  C. Iliescu,  R. Patten,  B. Walters,  S. Shevtsov,  J.B. Durand,  T. Force, 
  • Page: 162
  • First Published: 20 July 2007
Free Access

706 Monitoring of cardiotoxicity in oncology patients treated with anthracyclines

J.M. Horacek,  R. Pudil,  M. Tichy,  L. Jebavy, 
  • Page: 162
  • First Published: 20 July 2007
Free Access

707 Cardiac effects of pegylated liposomal doxorubicin in elderly patients with aggressive lymphomas

C. Lafaras, 
  • Page: 162
  • First Published: 20 July 2007
Free Access

708 Pathogenesis and monitoring of anthracycline induced cardiomyopathy: role of endothelin-1, brain natriuretic peptide and serial echocardiography

K. Keltai,  A. Zsary,  E. Pasztor,  T. Schneider,  P. Sarman,  A. Rosta,  I. Karadi,  L. Janoskuti, 
  • Pages: 162-163
  • First Published: 20 July 2007
Free Access

709 Assessment of myocardial perfusion in chemical warfare patients intoxicated with mustard gas

A. Gholamrezanezhad,  M. Saghari,  A. Vakili,  S. Mirpour,  M. Farahani, 
  • Page: 163
  • First Published: 20 July 2007
Free Access

710 Renal dysfunction in patients with diastolic heart failure, different biochemical parameters and its prognostic value in one year follow up

M. Roik,  M.H. Starczewska,  S. Stawicki,  A. Oreziak,  J. Kochanowski,  Z. Huczek,  G. Opolski, 
  • Page: 163
  • First Published: 20 July 2007
Free Access

711 The etiology and prognostic significance of all-cause troponin I positivity in emergency patients

T.J. Ilva,  M.J. Eskola,  K.C. Nikus,  K.O. Niemela,  P.J. Karhunen,  J. Lund,  L.-M. Voipio-Pulkki,  P. Porela, 
  • Page: 164
  • First Published: 20 July 2007
Free Access

712 Prediction of left ventricular dysfunction in basis of ventricular depolarisation time and electrical axis in patients with left bundle branch block

S.M. Miri,  S. Jalali,  P. Karimi, 
  • Page: 164
  • First Published: 20 July 2007
Free Access

713 Usefulness of regional wall motion analysis by echocardiography and late gadolinium-enhanced cardiovascular MRI in diagnosis of ischemica cardiomyopathy

A. Trigo,  C.J. Soriano,  F. Ridocci Soriano,  J. Estornell,  M. Gimenez,  M. Nadal,  J. Sanchez,  R. Paya, 
  • Page: 164
  • First Published: 20 July 2007
Free Access

714 Withdrawn Causes of chronic dyspnoea in patients of cardiology clinic

A. Syrkin,  M. Poltavskaya,  E. Sarkisova,  A. Doletski,  M. Kuklina, 
  • Pages: 164-165
  • First Published: 20 July 2007
Free Access

715 A survey of the primary-secondary care interface for patients with suspected heart failure in England

J.J. Murphy,  R. Chakraborty,  G. Brennan,  A. Fuat,  M.K. Davies,  J.G.F. Cleland, 
  • Page: 165
  • First Published: 20 July 2007
Free Access

716 P38 MAP kinase inhibition attenuates left ventricular dysfunction by down regulating of pro-inflammatory cardiac cytokines in an animal model of diabetes mellitus

D. Westermann,  S. Rutschow,  A. Linderer,  H.-P. Schultheiss,  M. Pauschinger,  S. van Linthout,  C. Tschope, 
  • Page: 165
  • First Published: 20 July 2007
Free Access

717 Chromogranin A is produced by human ventricular myocardium in systolic and diastolic heart failure and exerts negative inotropic and lusitropic effects on mammalian heart

M. Pieroni,  A. Corti,  C. Chimenti,  B. Tota,  M.A. Russo,  A. Maseri,  C. Gaudio,  A. Frustaci, 
  • Pages: 165-166
  • First Published: 20 July 2007
Free Access

718 Prognostic value of cytokines in stable heart failure patients

F. Frioes,  A. Azevedo,  R. Almeida,  J.T. Guimaraes,  A. Ferreira,  P. Bettencourt,  F. Rocha-Goncalves, 
  • Page: 166
  • First Published: 20 July 2007
Free Access

719 Cardiotrophin-1 predicts heart failure or death following acute myocardial infarction

S.Q. Khan,  D. Kelly,  P. Quinn,  L.L. Ng, 
  • Pages: 166-167
  • First Published: 20 July 2007
Free Access

720 Interleukin-4 urinary levels are related with myocardial fibrosis in heart failure patients

E. Rosello,  M. Rivera Otero,  L. Mainar,  M.J. Sancho Tello,  V. Miro,  B. Sevilla,  A. Jordan,  A. Gonzalez Molina, 
  • Page: 167
  • First Published: 20 July 2007
Free Access

721 Acute pulmonary edema complicating systolic and diastolic heart failure. Biological markers

E.-T. Siniorakis,  C. Lembessopoulos,  A. Kotsanis,  S. Kanderakis,  S. Kartas,  M. Michailidou,  N. Sakarelou,  P. Bonoris, 
  • Page: 167
  • First Published: 20 July 2007
Free Access

722 Asymmetrical dimethylarginine (ADMA) is elevated in heart failure, independently from oxidative stress and inflammatory status

D. Tousoulis,  I. Andreou,  C. Antoniades,  C. Vassiliadou,  K. Marinou,  G. Siasos,  M. Karali,  C. Stefanadis, 
  • Page: 167
  • First Published: 20 July 2007
Free Access

723 Prognostic value of plasma N-terminal pro-brain natriuretic peptide, interleukin 6, tumor necrosis factor alpha and soluble CD40 ligand in acute heart failure

R. Pudil,  M. Tichy,  C. Andrys,  V. Blaha,  J. Vojacek,  on behalf of The research project MSM0021620817 and MZO 00179906 , 
  • Page: 168
  • First Published: 20 July 2007
Free Access

724 Low doses of statins improve neurohumoral activity in patients with moderate-to-severe congestive heart failure due to coronary artery disease

A. Berezin, 
  • Page: 168
  • First Published: 20 July 2007
Free Access

725 Immunomodulatory effects of thymulin in monocrotalin-induced pulmonary hypertension

S.M. Oliveira,  T. Henriques-Coelho,  F. La Fuente-Carvalho,  A. Brandao-Nogueira,  M. Santos,  J. Correia-Pinto,  A. Leite-Moreira, 
  • Pages: 168-169
  • First Published: 20 July 2007
Free Access

726 The increased inflammatory response seen in heart failure is related to the severity of tricuspid regurgitation rather than the severity of LV impairment

J. Windram,  P.H. Loh,  L. Tin,  A.L. Clark,  J.G.F. Cleland, 
  • Page: 169
  • First Published: 20 July 2007
Free Access

727 Beta-adrenergic stimulation acutely increases myocardial distensibility: a novel PKA, PKC and Na+/H+ exchanger-mediated effect

A.P. Fontes-Sousa,  I. Falcao-Pires,  C. Bras-Silva,  A. Leite-Moreira, 
  • Page: 169
  • First Published: 20 July 2007
Free Access

728 The levosimendan metabolite OR-1896 elicits vasodilation by activating the KATP and BKCa channels in isolated arterioles of the rat

N. Erdei,  Z. Papp,  P. Pollesello,  I. Edes,  Z. Bagi, 
  • Page: 169
  • First Published: 20 July 2007
Free Access

729 The effect of CRT on the pharmacological treatment of patients with heart failure and cardiac dyssynchrony

J.G.F. Cleland,  M. Marijianowski,  L. Tavazzii,  N. Freemantle,  J.C. Daubert,  D. Gras,  L. Kappenberger, 
  • Page: 170
  • First Published: 20 July 2007
Free Access

730 Bosentan improves both pulmonary vascular and cardiac remodeling in experimental flow-associated pulmonary hypertension

M.E. Van Albada,  M.C. Houwertjes,  R.M.F. Berger,  R.G. Schoemaker, 
  • Page: 170
  • First Published: 20 July 2007
Free Access

731 Benefit of vasodilator treatment in pulmonary arterial hypertension related to HIV-infection (PAHRH)

T. Konorza,  P. Krings,  T. Neumann,  J. Kondratieva,  R. Erbel, 
  • Pages: 170-171
  • First Published: 20 July 2007
Free Access

732 Responsiveness to inhaled nitric oxide in patients with pulmonary arterial hypertension and right heart failure

P. Podolec,  M. Kaznica-Wiatr,  M. Hlawaty,  P. Wilkolek,  Z. Podolec,  G. Kopec,  W. Tracz, 
  • Page: 171
  • First Published: 20 July 2007
Free Access

733 Reversal of the refractory pulmonary hypertension after heart transplantation

J.S. Correia,  L. Oliveira,  S. Costa,  F. Franco Silva,  A. Marinho Silva,  L. Goncalves,  M. Antunes,  L.A. Providencia, 
  • Page: 171
  • First Published: 20 July 2007
Free Access

734 Administration of apelin increases inotropism and myocardial performance in mct-induced pulmonary hypertension

I. Falcao-Pires,  T. Henriques-Coelho,  N. Goncalves,  D. Goncalves,  A. Leite-Moreira, 
  • Pages: 171-172
  • First Published: 20 July 2007
Free Access

735 BNP guided care by a heart failure specialist in addition to home-based nurse care in patients with chronic heart failure

R. Berger,  D. Moertl,  M. Huelsmann,  R. Achmadi,  R. Pacher, 
  • Page: 172
  • First Published: 20 July 2007
Free Access

736 Changes in self-care behaviour along time assessed with the European Heart Failure Self-care Behaviour Scale in a Heart Failure Unit

B. Gonzalez,  J. Lupon Roses,  A. Urrutia,  A. Wilke,  S. Altimir,  C. Diez,  R. Coll,  V. Valle, 
  • Page: 172
  • First Published: 20 July 2007
Free Access

737 Patients' self-care improvement with nurse education intervention assessed by the European Heart Failure Self-care Behaviour Scale in a Heart Failure Unit in Spain

B. Gonzalez,  J. Lupon Roses,  A. Urrutia,  A. Wilke,  S. Altimir,  C. Diez,  R. Coll,  V. Valle, 
  • Pages: 172-173
  • First Published: 20 July 2007
Free Access

738 Nurses' knowledge of advising heart failure patients

L.P. Partanen, 
  • Page: 173
  • First Published: 20 July 2007
Free Access

739 The objective burden in partners of Heart Failure patients; a new measurement tool

M.L. Luttik,  T. Jaarsma,  D.J. van Veldhuisen,  R. Sandermann, 
  • Page: 173
  • First Published: 20 July 2007
Free Access

740 Effect of metoprolol on the antioxidative status in chronic heart failure

A. Campeanu,  I.R. Zaharia,  R. Olinescu, 
  • Pages: 173-174
  • First Published: 20 July 2007
Free Access

741 The Health Buddy: telemonitoring system for patients with heart failure

H.J.M. Vrijhoef,  Janssen-Boyne,  G. Engering,  J.A. Kragten,  G.J. De Weerd,  M. Frederix,  A.P.M. Gorgels, 
  • Page: 174
  • First Published: 20 July 2007
Free Access

742 Inability to reach optimal neurohormonal blockade predicts poor survival and higher rehospitalisation rate in patients with heart failure

M. Roik,  M.H. Starczewska,  S. Stawicki,  J. Kochanowski,  Z. Huczek,  G. Opolski, 
  • Page: 174
  • First Published: 20 July 2007
Free Access

743 Redefining outlook for survivors of class IV heart failure admission: Long term follow up of 536 patients in a hospital based disease management programme

C. O'Loughlin,  N. Murphy,  C. Conlon,  C. Traynor,  C. Ryan,  M. Ledwidge,  K. Mcdonald, 
  • Page: 175
  • First Published: 20 July 2007
Free Access

744 First mortality data of a health care network of patients with congestive heart failure: benefit observed comparing to the patients included in a prospective register

M. Bonarek,  A. Hadjo,  P. Lauribe,  D. Benchimol,  P. Matis,  M.P. Bienvenu,  J.F. Dartigues,  H. Benchimol, 
  • Page: 175
  • First Published: 20 July 2007
Free Access

745 Cardiac diagnostic procedures and drug prescription from regional administrative databases in community heart failure (HF) patients: is there room for improvement?

R. De Maria,  S. Capomolla,  F. Clemenza,  F. Oliva,  G. Castelli,  G. Di Tano,  A. Mortara,  A. Di Lenarda,  on behalf of Working Group on Heart Failure, Italian Hospital Cardiologists Ass. , 
  • Pages: 175-176
  • First Published: 20 July 2007
Free Access

746 Treatment of severe heart failure due to left-to-right shunting in pediatric patients

O. Andersen,  P. Harding,  B. Allgeier,  R. Motz, 
  • Page: 176
  • First Published: 20 July 2007
Free Access

747 Effects of statins in pulmonary hypertension in patients with severe chronic heart failure

A. Rylova,  N. Rylova,  G. Arutyunov, 
  • Page: 176
  • First Published: 20 July 2007
Free Access

748 Effect of long-term simvastatin therapy on pulmonary artery pressure in patients with severe CHF

A. Rylova,  G. Arutyunov,  N. Rylova, 
  • Page: 176
  • First Published: 20 July 2007
Free Access

749 Correction of normochromic anemia in patients with CHF by the method of nutritive support

A. Rylova,  G. Arutyunov,  O. Kostyukevich, 
  • Pages: 176-177
  • First Published: 20 July 2007
Free Access

750 Structural alterations of large intestinal wall in patients with chronic heart failure of different classes

A. Rylova,  G. Arutyunov,  L. Kafarskaya,  N. Savelov,  N. Bylova,  N. Kokosadze,  A. Risnenko,  Z. Chernaya, 
  • Page: 177
  • First Published: 20 July 2007
Free Access

751 Changed microflora in large intestine of patients with chronic heart failure of different classes

A. Rylova,  G. Arutyunov,  L. Kafarskaya,  N. Savelov,  N. Bylova,  N. Kokosadze,  A. Risnenko,  Z. Chernaya, 
  • Page: 177
  • First Published: 20 July 2007
Free Access

752 Kidney disease in patients with chronic heart failure - impact on intracardiac conduction, diastolic function and prognosis

C. Bruch,  F. Huelsmann,  M. Grude,  R. Gradaus,  L. Eckardt, 
  • Page: 177
  • First Published: 20 July 2007
Free Access

753 Changes in the concentration of neurohormones and inflammatory markers in patients with heart failure and diabetes after beta-adrenergic blockade with carvedilol

J. Nessler,  M. Kitlinski,  B. Nessler,  M. Stepniewski,  W. Piwowarska, 
  • Page: 178
  • First Published: 20 July 2007
Free Access

754 Frailty is strongly associated to cardio-renal-anemia syndrome in elderly community-living heart failure patients

D. Del Sindaco,  G. Pulignano,  A. Di Lenarda,  G. Minardi,  C. Manzara,  G. Sinagra,  E. Giovannini,  E. Leggio, 
  • Page: 178
  • First Published: 20 July 2007
Free Access

755 Exercise induced periodic breathing is reduced by added dead space

A. Apostolo,  R. Albert,  P. Palermo,  M. Contini,  G. Cattadori,  P. Agostoni, 
  • Pages: 178-179
  • First Published: 20 July 2007
Free Access

756 Endothelial dysfunction and tolerance to loop diuretic withdrawn in patients with stabilized heart failure and systolic dysfunction

H. Rus,  A. Bisoc,  C. Ciurea,  M. Radoi,  M. Nan, 
  • Page: 179
  • First Published: 20 July 2007
Free Access

757 Tricuspid inflow measurements and tissue Doppler echocardiography in the assessment of right ventricular diastolic dysfunction in heart failure

W. Biegalski,  K. Poprawski,  M. Michalski,  K. Kandziora,  R. Dankowski,  A. Piatkowska,  A. Nowicka,  M. Wierzchowiecki, 
  • Page: 179
  • First Published: 20 July 2007
Free Access

758 Right ventricular systolic function in patients with systolic and diastolic left ventricular heart failure

W. Biegalski,  K. Poprawski,  M. Kandziora,  M. Michalski,  R. Dankowski,  A. Piatkowska,  A. Nowicka,  M. Wierzchowiecki, 
  • Pages: 179-180
  • First Published: 20 July 2007
Free Access

759 Tissue Doppler derived right ventricular myocardial time intervals in heart failure patients

W. Biegalski,  K. Poprawski,  M. Kandziora,  M. Michalski,  R. Dankowski,  A. Piatkowska,  K. Szymanowska,  M. Wierzchowiecki, 
  • Page: 180
  • First Published: 20 July 2007
Free Access

760 Beta-adrenergic receptor blockers as part of management of heart failure therapy in Africa - very little evidence

V.P. Vaghela,  K. Sliwa,  M.R. Essop,  J.E. Sanderson, 
  • Page: 180
  • First Published: 20 July 2007
Free Access

761 Therapy in elderly patients (75 or more years) with heart failure. A comparative study with younger patients

A. Urrutia,  J. Lupon Roses,  B. Gonzalez,  A. Wilke,  R. Coll,  S. Altimir,  C. Diez,  V. Valle, 
  • Pages: 180-181
  • First Published: 20 July 2007
Free Access

762 Outpatient ultrafiltration in warm and wet refractory heart failure: a single centre experience

A. Comella,  M. Magnacca,  R. Poddighe,  S. Stroppa,  G. Casolo, 
  • Page: 181
  • First Published: 20 July 2007
Free Access

763 Outcome predictors for intermittent ultrafiltration in congestive heart failure patients

A. Comella,  M. Magnacca,  R. Poddighe,  S. Stroppa,  G. Casolo, 
  • Page: 181
  • First Published: 20 July 2007
Free Access

764 Serum NT-proBNP measured 4-5 days after ST-elevation myocardial infarction is the best marker of early left ventricular dysfunction in patients treated with primary coronary angioplasty

I. Koska,  J.H. Goch,  L. Polak,  M. Maciejewski,  K. Chizynski, 
  • Pages: 181-182
  • First Published: 20 July 2007
Free Access

765 Age effect in mild to moderate heart failure: baseline echocardiographic data from the AntiRemodeling Effect of CAnrenone IN Patients With Mild Chronic Heart Failure (AREA-IN-CHF) study

G.F. Mureddu,  G. Cacciatore,  G. De Simone,  A. Gavazzi,  S. Masson,  A. Di Lenarda,  A.P. Maggioni,  A. Boccanelli, 
  • Page: 182
  • First Published: 20 July 2007
Free Access

766 Left ventricular filling characteristics in mild to moderate heart failure: baseline data from the AntiRemodeling Effect of CAnrenone IN Patients With Mild Chronic Heart Failure (AREA IN CHF) study

G.F. Mureddu,  G. Cacciatore,  G. De Simone,  R. Latini,  D. Lomaglio,  A. Gavazzi,  A.P. Maggioni,  A. Boccanelli, 
  • Page: 182
  • First Published: 20 July 2007
Free Access

767 Gender-related echocardiographic characteristics in mild to moderate heart failure: baseline data from the AntiRemodeling Effect of CAnrenone IN Patients With Mild Chronic Heart Failure study

G.F. Mureddu,  G. Cacciatore,  G. De Simone,  M. Porcu,  S. Urgese,  M. Vanasia,  A.P. Maggioni,  A. Boccanelli, 
  • Pages: 182-183
  • First Published: 20 July 2007
Free Access

768 Assessment of the effect of an outward patient clinic and home-based intervention on the economic burden of management for chronic heart failure

Y.-L. Ho,  T. Hsu,  Y. Lin,  R. Hsu,  C. Lee,  N. Chou,  S. Wang,  M. Chen, 
  • Page: 183
  • First Published: 20 July 2007
Free Access

769 Six-minute walk performance in octogenarians patients after cardiac surgery

M. Piccoli,  A. Villa,  E. Cerquetani,  F. Scimia,  G. Pastena,  I. Casadei,  M.D. Romeo,  G. Gambelli,  A. Salustri, 
  • Page: 183
  • First Published: 20 July 2007
Free Access

770 An elevated cholesterol has a protective effect in patients with heart failure who have an increased inflammatory response

J. Windram,  P.H. Loh,  L. Tin,  A.L. Clark,  J.G.F. Cleland, 
  • Pages: 183-184
  • First Published: 20 July 2007
Free Access

771 Race and the response to treatment in patients with advanced heart failure

J. Byrne,  J. De Courcey,  R. Buckley,  H. Williams,  A. Ajembe,  M. Kearney, 
  • Page: 184
  • First Published: 20 July 2007
Free Access

772 A low dose of carperitide, an atrial natriuretic peptide, improves left ventricular diastolic dysfunction validated using tissue Doppler imaging in patients with idiopathic dilated cardiomyopathy

M. Kato,  K. Hashimura,  M. Kitakaze, 
  • Page: 184
  • First Published: 20 July 2007
Free Access

773 Safety and efficacy of six-month outpatient intermittent nesiritide infusions

M. Sheikh-Taha, 
  • Pages: 184-185
  • First Published: 20 July 2007
Free Access

774 Highly selective beta-1 blocker bisoprolol significantly improves long-term prognosis in asymptomatic heart failure patients

A. Berezin, 
  • Page: 185
  • First Published: 20 July 2007
Free Access

775 Heart failure with low and preserved ejection fraction: similar morbimortality though different physiopathology

J.C. Castillo,  M. Anguita,  F. Esteban,  C. Duran,  A. Moreno,  G. Hernandez,  S. Ojeda,  J. Suarez de Lezo, 
  • Page: 185
  • First Published: 20 July 2007
Free Access

776 Correlation of obesity and mortality in patients admitted for heart failure

C. Caltea,  A.-E. Caltea,  V. Chioncel,  C. Sinescu, 
  • Page: 185
  • First Published: 20 July 2007
Free Access

777 Presence of desmin in cardiomyocytes and long-term prognosis in patients with chronic heart failure

R.J. Gil,  A. Pawlak,  E. Walczak,  H. Rdzanek,  T. Wagner,  J. Rzezak,  A. Slysz, 
  • Page: 186
  • First Published: 20 July 2007
Free Access

778 Relationship between desmin presence in cardiomyocytes and left ventricle function in patients with chronic heart failure

A. Pawlak,  R.J. Gil,  E. Walczak,  H. Rdzanek,  P. Seweryniak,  R. Krzyzewski, 
  • Page: 186
  • First Published: 20 July 2007
Free Access

779 N-terminal pro brain natriuretic peptide predicts exercise tolerance in heart transplant recipients

B. Stanek,  R. Berger,  A. Aliabadi,  S. Roedler,  M. Grimm, 
  • Page: 186
  • First Published: 20 July 2007
Free Access

780 Atorvastatin in chronic heart failure. (Randomized prospective open-label study)

O.I. Dyadyk,  A.E. Bagriy,  L. Kholopov, 
  • Page: 187
  • First Published: 20 July 2007
Free Access

781 Haemodilution is the primary cause of mild anaemia in heart failure

L. Tin,  K. Goode,  A. Tweddel,  P.H. Loh,  R. Shelton,  J. Windram,  R. Davies,  J.G.F. Cleland, 
  • Page: 187
  • First Published: 20 July 2007
Free Access

782 The prohormone proBNP1-108 as new heart failure biomarker

I. Giuliani,  C. Larue,  E. Merigeon,  D. Merle,  F. Rieunier,  J.P. Cristol,  S. Villard, 
  • Page: 187
  • First Published: 20 July 2007
Free Access

783 Clinical significance of renal function dynamics in patients hospitalized with decompensated chronic heart failure - one year follow-up study

M.H. Starczewska,  M. Roik,  S. Stawicki,  G. Opolski, 
  • Page: 188
  • First Published: 20 July 2007
Free Access

784 Is initiation or continuation of statin therapy following diagnosis of heart failure associated with lower all-cause mortality in patients with coronary artery disease?

P.H. Loh,  J. Windram,  L. Tin,  P. Reddy,  A.S. Rigby,  N.P. Nikitin,  A.L. Clark,  J.G.F. Cleland, 
  • Page: 188
  • First Published: 20 July 2007
Free Access

785 Causes of death on heart failure

M. Anastasiu,  C. Mihai,  C. Caltea,  C. Sinescu, 
  • Pages: 188-189
  • First Published: 20 July 2007
Free Access

786 Statin therapy is associated with lower mortality among patients with ischemic heart failure. Date from one center study

S. Stawicki,  M. Roik,  D.A. Kosior,  M.H. Starczewska,  Z. Tomik,  O. Warszawik,  G. Opolski, 
  • Page: 189
  • First Published: 20 July 2007
Free Access

787 Prognostic value of admission glucose of hospitalized non-diabetic patients with heart failure

S. Stawicki,  M. Roik,  D.A. Kosior,  M.H. Starczewska,  O. Warszawik,  G. Opolski, 
  • Page: 189
  • First Published: 20 July 2007
Free Access

788 Serial NT.proBNP determinations for the management of chronic heart failure

A. De Bernardi,  M.T.S. Spinnler, 
  • Page: 189
  • First Published: 20 July 2007
Free Access

789 Tei Index in patients with chronic heart failure

B. Bart,  M. Alekhin,  V. Larina,  J. Bart, 
  • Page: 190
  • First Published: 20 July 2007
Free Access

790 Effects of a multidisciplinary disease management program on recurrent hospitalisation in elderly patients with heart failure

V. Annoni,  L. Denti,  G.P. Ceda,  L. Marchini, 
  • Page: 190
  • First Published: 20 July 2007
Free Access

791 The heart failure unit at the Rabin Medical Center: a multidisciplinary team management programme

V. Yaari,  A. Pinchas,  O. Damari,  G. Sahar,  A. Battler,  T. Ben Gal, 
  • Page: 190
  • First Published: 20 July 2007
Free Access

792 Antiremodeling effect of canrenone in patients with mild chronic heart failure: AREA IN CHF study. Baseline data of patients

G. Cacciatore,  G.F. Mureddu,  A.P. Maggioni,  G. De Simone,  M. Vanasia,  S. Masson,  R. Latini,  A. Boccanelli, 
  • Page: 191
  • First Published: 20 July 2007
Free Access

793 Different effects of carvedilol and bisoprolol on lung function in congestive heart failure at rest and during exercise

M. Contini,  A. Apostolo,  P. Palermo,  G. Cattadori,  D. Andreini,  M. Bussotti,  P. Agostoni, 
  • Page: 191
  • First Published: 20 July 2007
Free Access

794 Integrated care pathways for heart failure (HF) patients: a national consensus initiative

A. Di Lenarda,  F. Oliva,  R. De Maria,  G. Gigli,  G. Alunni,  L. Tarantini,  G. Pulignano,  A. Mortara, 
  • Page: 191
  • First Published: 20 July 2007
Free Access

795 Prevalence and prognosis of HF in post MI patients

A. Torabi,  J.G.F. Cleland,  N.K. Khan,  P.H. Loh,  J. Windram,  P. Velavan,  K. Good, 
  • Page: 192
  • First Published: 20 July 2007
Free Access

796 Still a mysterious and a challenge face of heart failure in elderly: the prevalence, clinical features and the prognosis significance of preserve versus impaired systolic function

D. Toporan,  M. Vintila, 
  • Page: 192
  • First Published: 20 July 2007
Free Access

797 What do primary care physicians know about congestive heart failure diagnosis and treatment in the district of Poznan, Poland?

M. Wierzchowiecki,  K. Poprawski,  A. Nowicka,  M. Kandziora,  A. Piatkowska, 
  • Page: 192
  • First Published: 20 July 2007
Free Access

798 Quantum therapy effect in anemic heart failure patients

I. Alizade,  N.T. Aliyeva-Karayeva, 
  • Pages: 192-193
  • First Published: 20 July 2007
Free Access

799 Cardiovascular complications of Thalassemia major and Thalassemia intermedia

M. Saravi,  A. Tamadoni, 
  • Page: 193
  • First Published: 20 July 2007

Author Index

Free Access

Author Index

  • Pages: 195-208
  • First Published: 20 July 2007

Index of Topics

Free Access

Index of Topics

  • Pages: 210-212
  • First Published: 20 July 2007